Maternal Diseases Complicating Pregnancy: Diabetes, Tumors, Preeclampsia, Lupus Anticoagulant

  • Kurt Benirschke
  • Peter Kaufmann


Numerous diseases may complicate pregnancy. The most important of those that affect placental development and function are herein reviewed. Our own experience with some of these entities is added. With some of these complications of pregnancy, the placental findings may simply be confirmatory of the disease. With others, placental pathology may be the first indication of an abnormality. Despite many reports of diseases that complicate pregnancy, associated placentas are often not examined, or they are not reported in the descriptions. It is unfortunate because those placentas could aid in diagnosis and knowledge of the pathogenesis of these conditions. Moreover, a better understanding of the placenta could allow us better insight into the mechanisms of the effects that certain conditions have on the fetus. Burrow and Ferris (1988) have written a comprehensive text on medical complications of pregnancy but have also almost totally excluded placental considerations. Because of their particular importance, some entities (e.g., Rh isoimmunization disease and hydrops, pyelonephritis, and infections in general are presented in other chapters).


Systemic Lupus Erythematosus Disseminate Intravascular Coagulation Lupus Anticoagulant Diabetic Mother Maternal Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdella, T.N., Sibai, B.M., Hays, J.M., and Anderson, G.D.: Relationship of hypertensive disease to abruptio placentae. Obstet. Gynecol. 63: 365–370, 1984.PubMedGoogle Scholar
  2. Abitbol, M.M., Driscoll, S.G., and Ober, W.B.: Placental lesions in experimental toxemia in the rabbit. Am. J. Obstet. Gynecol. 125: 942–948, 1976a.PubMedGoogle Scholar
  3. Abitbol, M.M., Gallo, G.R., Pirani, C.L., and Ober, W.B.: Production of experimental toxemia in the pregnant rabbit. Am. J. Obstet. Gynecol. 124: 460–470, 1976b.PubMedGoogle Scholar
  4. Abitbol, M.M., Pirani, C.L., Ober, W.B., Driscoll, S.G., and Cohen, M.W.: Production of experimental toxemia in the pregnant dog. Obstet. Gynecol. 48: 537–548, 1976c.PubMedGoogle Scholar
  5. Abitbol, M.M., Ober, W.B., Gallo, G.R., Driscoll, S.G., and Pirani, C.L.: Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am. J. Pathol. 86: 573–590, 1977.PubMedGoogle Scholar
  6. Abramowsky, C.R., Vegas, M.E., Swinehart, G., and Gyves, M.T.: Decidual vasculopathy of the placenta in lupus erythematosus. N. Engl. J. Med. 303: 668–672, 1980.PubMedCrossRefGoogle Scholar
  7. Acker, D., Sachs, B.P., Tracey, K.J., and Wise, W.E.: Abruptio placentae associated with cocaine use. Am. J. Obstet. Gynecol. 146: 220–221, 1983.PubMedGoogle Scholar
  8. ACOG: Thyroid disease in pregnancy. ACOG Techn. Bull. 181: 1–6, 1993.Google Scholar
  9. Adam, P.A.J., Teramo, K., Raiha, N., Gitlin, D., and Schwartz, R.: Human fetal insulin metabolism early in gestation: response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-131. Diabetes 18: 409–416, 1969.PubMedGoogle Scholar
  10. Addleman, W., and Gold, S.: Gaucher’s disease and pregnancy. Can. Med. Assoc. J. 89: 821–823, 1963.PubMedGoogle Scholar
  11. Ahnquist, G., and Holyoke, J.B.: Congenital Letterer-Siwe disease (reticuloendotheliosis) in a term stillborn infant. J. Pediatr. 57: 897–904, 1960.PubMedCrossRefGoogle Scholar
  12. Aladjem, S.: Morphologic aspects of the placenta in gestational diabetes seen by phase-contrast microscopy. Am. J. Obstet. Gynecol. 99: 341–349, 1967a.PubMedGoogle Scholar
  13. Aladjem, S.: The syncytial knot: a sign of active syncytial proliferation. Am. J. Obstet. Gynecol. 99: 350–358, 1967b.PubMedGoogle Scholar
  14. Aladjem, S., Lueck, J., and Brewer, J.I.: Experimental induction of a toxemia-like syndrome in the pregnant beagle. Am. J. Obstet. Gynecol. 145: 27–38, 1983.PubMedGoogle Scholar
  15. Alanen, A., Kekomäki, R., Kero, P., Lindström, P., and Wager, O.: Circulating immune complexes in hypertensive disorders of pregnancy. J. Reprod. Immunol. 6: 133–140, 1984.PubMedCrossRefGoogle Scholar
  16. Alberman, E., Pharoah, P., and Chamberlain, G.: Smoking and the fetus. Lancet 2: 36–37, 1977.Google Scholar
  17. Altchek, A., Gaines, J.A., and Siltzbach, L.E.: Sarcoidosis of the uterus. Am. J. Obstet. Gynecol. 70: 540–547, 1955.PubMedGoogle Scholar
  18. Alvarez, H.: Prolifration du trophoblaste et sa relation avec l’hypertension artrielle de la toxmie gravidique. Gynecol. Obstet. (Paris) 69: 581–588, 1970.Google Scholar
  19. Alvarez, H., Benedetti, W.L., and DeLeons, V.K.: Syncytial proliferation in normal and toxemic pregnancies. Obstet. Gynecol. 29: 637–643, 1967.PubMedGoogle Scholar
  20. Alvarez, H., Morel, R.L., Benedetti, W.L., and Scavarelli, M.: Trophoblast hyperplasia and maternal arterial pressure at term. Am. J. Obstet. Gynecol. 105: 1015–1021, 1969.PubMedGoogle Scholar
  21. Alzamora, O.: Algunas observaciones sobre las alteraciones de la placenta human en la altura. Rev. Asoc. Med. Prov. Yauli. 3: 75, 1958.Google Scholar
  22. Ambrose, A., Welham, R.T., and Cefalo, R.C.: Thrombotic thrombocytic purpura in early pregnancy. Obstet. Gynecol. 66: 267–272, 1985.PubMedGoogle Scholar
  23. Anderson, J.F., Kent, S., and Machin, G.A.: Maternal malignant melanoma with placental metastasis: a case report with literature review. Pediatr. Pathol. 9: 35–42, 1989.PubMedCrossRefGoogle Scholar
  24. Anderson, M., Went, L.N., Maclver, J.E., and Dixon, H.G.: Sickle cell disease in pregnancy. Lancet 2:516–521, 1960. Anderson, W.R., and McKay, D.G.: Electron microscope study of the trophoblast in normal and toxemic placentas. Am. J. Obstet. Gynecol. 95: 1134–1148, 1966.Google Scholar
  25. Andrews, J., and McGarry, J.: A community study of smoking in pregnancy. J. Obstet. Gynaecol. Br. Commonw. 79: 1057–1073, 1972.PubMedCrossRefGoogle Scholar
  26. Anonymous: Pregnancy and the arachidonic-acid cascade. Lancet 1: 997–998, 1982.Google Scholar
  27. Anonymous: Classification of hypertensive disorders of pregnancy. Lancet 1: 935–936, 1989a.Google Scholar
  28. Anonymous: Smoke screen round the fetus. Lancet 2: 13101311, 1989b.Google Scholar
  29. Anunciado, A.N., Stubbs, T.M., Pepkowitz, S.H., Lazarchick, J., Miller III, C.M., and Pilia, P.: Altered villus vessel fibronectin in preeclampsia. Am. J. Obstet. Gynecol. 156: 898–900, 1987.PubMedGoogle Scholar
  30. Aron, D.C., Schnall, A.M., and Sheeler, L.R.: Cushing’s syndrome and pregnancy. Am. J. Obstet. Gynecol. 162: 244–252, 1990.PubMedGoogle Scholar
  31. Aronson, S.: A case of transplacental tumor metastasis. Acta Paediatr. (Stockh.) 52: 123–124, 1963.Google Scholar
  32. Asherson, R.A., Khamashta, M.A., Ordi-Ros, J., Derksen, R.H.D.M., Machin, S.J., Barquinero, J., Outt, H.H., Harris, E.N., Vilardell-torres, M., and Hughes, G.R.V.: The “primary” antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68: 366–374, 1989.Google Scholar
  33. Ask-Upmark, E.: Leukemia and pregnancy. Acta Med. Scand. 170: 635–658, 1961.Google Scholar
  34. Ask-Upmark, E.: Another follow-up study of children born of mothers with leukemia. Acta Med. Scand. 175: 391–394, 1964.Google Scholar
  35. Asmussen, I.: Ultrastructure of human umbilical veins: observations on veins from newborn children of smoking and nonsmoking mothers. Acta Obstet. Gynecol. Scand. 57: 253–255, 1978.CrossRefGoogle Scholar
  36. Asmussen, I.: Effects of maternal smoking on the cardiovascular system. Cardiovasc. Med. 4: 777–790, 1979.Google Scholar
  37. Asmussen, I.: Ultrastructure of the villi and fetal capillaries in placentas from smoking and nonsmoking mothers. Br. J. Obstet. Gynaecol. 87: 239–245, 1980.PubMedCrossRefGoogle Scholar
  38. Asmussen, I.: Ultrastructure of human umbilical arteries from newborn children of smoking and non-smoking mothers. Acta Pathol. Microbiol. Immunol. Scand. A 90: 375–383, 1982a.Google Scholar
  39. Asmussen, I.: Ultrastructure of the umbilical artery from a newborn delivered at term by a mother who smoked 80 cigarettes per day. Acta Pathol. Microbiol. Immunol. Scand. A 90: 397–404, 1982b.Google Scholar
  40. Asmussen, I.: Mitochondrial proliferation in endothelium: observations on umbilical arteries from newborn children of smoking mothers. Atherosclerosis 50: 203–208, 1984.PubMedCrossRefGoogle Scholar
  41. Atalla, A., and Page, I.: Ehlers-Danlos syndrome type III in pregnancy. Obstet. Gynecol. 71: 508–509, 1988.PubMedGoogle Scholar
  42. Attwood, H.D., and Park, W.W.: Embolism to the lungs by trophoblast. J. Obstet. Gynaecol. Br. Commonw. 68: 61 1617, 1961.Google Scholar
  43. Averbuch, M., Koifman, B., and Levo, Y.: Lupus anticoagulant, thrombosis and thrombocytopenia in systemic lupus erythematosus. Am. J. Med. 293: 2–5, 1987.CrossRefGoogle Scholar
  44. Ayala, A.R., De La Fuente, F.R., Loyola, F.D., Gonzalez, E., and Kunhardt, J.: Evidence that a toxemia-related organism (Hydatoxi lualba) is an artifact. Obstet. Gynecol. 67: 47–50, 1986.PubMedGoogle Scholar
  45. Bachrach, L.K., and Burrows, G.N.: Maternal-fetal transfer of thyroxine. N. Engl. J. Med. 321: 1549, 1989.CrossRefGoogle Scholar
  46. Balasch, J., Mirapeix, E., Borche, L., Vives, J., and Gonzalez-Merlo, J.: Further evidence against preeclampsia as an immune complex disease. Obstet. Gynecol. 58: 435–437, 1981.PubMedGoogle Scholar
  47. Baldwin, V.J., MacLeod, P.M., and Benirschke, K.: Placental findings in alcohol abuse in pregnancy. Birth Defects 18: 8994, 1982.Google Scholar
  48. Barabas, A.P.: Ehlers-Danlos syndrome: associated with prematurity and premature rupture of foetal membranes; possible increase in incidence. B.M.J. 2: 682–684, 1966.CrossRefGoogle Scholar
  49. Bardawil, W.A., and Toy, B.L.: The natural history of choriocarcinoma: problems of immunity and spontaneous regression. Ann. N.Y. Acad. Sci. 80: 197–261, 1959.PubMedCrossRefGoogle Scholar
  50. Bardeguez, A.D., McNerney, R., Frieri, M., Verma, U.L., and Tejani, N.: Cellular immunity in preeclampsia: alterations in T-lymphocyte subpopulations during early pregnancy. Obstet. Gynecol. 77: 859–862, 1991.PubMedGoogle Scholar
  51. Barnes, A.B., and Link, D.A.: Childhood dermatomyositis and pregnancy. Am. J. Obstet. Gynecol. 146: 335–336, 1983.PubMedGoogle Scholar
  52. Barss, V., Phillippe, M., Greene, M.F., and Covell, L.: Pregnancy complicated by homozygous hypercholesterolemia. Obstet. Gynecol. 65: 756–757, 1985.PubMedGoogle Scholar
  53. Bartholomew, R.A.: Hemorrhages of late pregnancy. with emphasis on placental circulation and the mechanism of bleeding. Postgrad. Med. 30: 397–406, 1961.PubMedGoogle Scholar
  54. Bartholomew, R.A., Colvin, E.D., Grimes, W.H., Fish, J.S., Lester, W.M., and Galloway, W.H.: Facts pertinent to the etiology of eclamptogenic toxemia. Am. J. Obstet. Gynecol. 74: 64–84, 1957.PubMedGoogle Scholar
  55. Bartholomew, R.A., Colvin, E.D., Grimes, W.H., Fish, J.S., Lester, W.M., and Galloway, W.H.: Criteria by which toxemia of pregnancy may be diagnosed from unlabeled formalin-fixed placentas. Am. J. Obstet. Gynecol. 82: 277–290, 1961.PubMedGoogle Scholar
  56. Beaufils, M., Uzan, S., Donsimoni, R., and Colau, J.C.: Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1: 840–842, 1985.PubMedCrossRefGoogle Scholar
  57. Beck, J.S., Oakley, C.L., and Rowell, N.R.: Transplacental passage of antinuclear antibody. Arch. Dermatol. 93: 656663, 1966.Google Scholar
  58. Beischer, N.A., Sivasamboo, R., Vohra, S., Silpisornkosal, S., and Reid, S.: Placental hypertrophy in severe pregnancy anaemia. J. Obstet. Gynaecol. Br. Commonw. 77: 398–409, 1970.PubMedCrossRefGoogle Scholar
  59. Beller, F.K., Intorp, H.W., Losse, H., Loew, H., Moenninghoff, W., Schmidt, E.H., and Grundmann, E.: Malignant nephrosclerosis during pregnancy and in the postpartum period (the uremic hemolytic syndrome). Am. J. Obstet. Gynecol. 125: 633–639, 1976.PubMedGoogle Scholar
  60. Belliardo, F., Massano, G., and Accomo, S.: Amatoxins do not cross the placental barrier. Lancet 1: 1381, 1983.PubMedCrossRefGoogle Scholar
  61. Bendon, R.W., Wilson, J., Getahun, B., and Bel-Kahn, J.v.d.: A maternal death due to thrombotic disease associated with anticardiolipin antibody. Arch. Pathol. Lab. Med. 111: 370–373, 1987.PubMedGoogle Scholar
  62. Benigni, A., Gregorini, G., Frusca, T., Chiabrando, C., Ballerini, S., Valcamonico, A., Orisio, S., Piccinelli, A., Pinciroli, V., Fanelli, R., Gastaldi, A., and Remuzzi, G.: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N. Engl. J. Med. 321: 357–362, 1989.PubMedCrossRefGoogle Scholar
  63. Benirschke, K., and Driscoll, S.G.: The Pathology of the Human Placenta. Springer-Verlag, New York, 1967.Google Scholar
  64. Benirschke, K., and Gille, J.: Placental pathology and asphyxia. In, Intrauterine Asphyxia and the Developing Fetal Brain. L. Gluck, ed. Year Book, Chicago, 1977.Google Scholar
  65. Bennett, R.M., Peller, J.S., and Merritt, M.M.: Defective DNA-receptor function in systemic lupus erythematosus and related diseases: evidence for an autoantibody influencing cell physiology. Lancet 1: 186–188, 1986.PubMedCrossRefGoogle Scholar
  66. Bentsi-Enchill, K.K., and Konotey-Ahulu, F.I.D.: Thirteen children from twelve pregnancies in sickle-cell thalassemia. B.M.J. 2: 762, 1969.CrossRefGoogle Scholar
  67. Bierman, H.R., Aggeler, P.M., Thelander, H., Kelly, K.H., and Cordes, F.L.: Leukemia and pregnancy. J.A.M.A. 161: 220–223, 1956.CrossRefGoogle Scholar
  68. Birkeland, S.A., and Kristofferson, K.: Pre-eclampsia—a state of mother-fetus immune imbalance. Lancet 2: 720–723, 1979.PubMedCrossRefGoogle Scholar
  69. Björk, O., and Persson, B.: Villous structure in different parts of the cotyledon in placentas of insulin-dependent diabetic women. Acta Obstet. Gynecol. Scand. 63: 37–43, 1984.CrossRefGoogle Scholar
  70. Blackburn, W.R., Kaplan, H.S., and McKay, D.G.: Morphologic changes in the developing rat placenta following prednisolone administration. Am. J. Obstet. Gynecol. 92: 234–246, 1965.PubMedGoogle Scholar
  71. Blakley, P.M.: Experimental teratology of ethanol. In, Issues and Reviews in Teratology. H. Kalter, ed., pp. 237–282. Plenum Press, New York, 1983.Google Scholar
  72. Blanc, W.A., Mattison, D.R., Kane, R., and Chauhan, P.: L.S.D., intrauterine amputations, and amniotic-band syndrome. Lancet 2: 158–159, 1971.PubMedCrossRefGoogle Scholar
  73. Bleyl, U., and Busing, C.M.: Disseminierte intravasale Gerinnung und perinataler Schock. Verh. Dtsch. Ges. Pathol. 53: 495–501, 1969.PubMedGoogle Scholar
  74. Boe, F.: Vascular changes in premature separation of the normally implanted placenta. Acta Obstet. Gynecol. Scand. 38: 441–443, 1951.CrossRefGoogle Scholar
  75. Bowie, E.J., Thompson, J.H., Pascuzzi, C.A., and Owen, C.A.: Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J. Lab. Clin. Med. 62: 416–430, 1963.PubMedGoogle Scholar
  76. Branch, D.W., Scott, J.R., Kochenour, N.K., and Hershgold, E.: Obstetric complications associated with the lupus anticoagulant. N. Engl. J. Med. 313: 1322–1326, 1985.PubMedCrossRefGoogle Scholar
  77. Branch, D.W., Andres, R., Digre, K.B., Rote, N.S., and Scott, J.R.: The association of antiphospholipid antibodies with severe preeclampsia. Obstet. Gynecol. 73: 541–545, 1989.PubMedGoogle Scholar
  78. Branch, D.W., and Rodgers, G.M.: Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am. J. Obstet. Gynecol. 168: 206–210, 1993.PubMedGoogle Scholar
  79. Brandt, J.T., Triplett, D.A., Musgrave, K., and Orr, C.: The sensitivity of different coagulation reagents to the presence of lupus anticoagulants. Arch. Pathol. Lab. Med. 111: 120124, 1987.Google Scholar
  80. Brent, R.L.: The indirect effect of radiation on embryonic development. II. Irradiation of the placenta. Am. J. Dis. Child. 100: 103–108, 1960.PubMedGoogle Scholar
  81. Bresnihan, B., Grigor, R.R., Oliver, M., Lewkonia, R.M., Hughes, G.R.V., Lovins, R.E., and Faulk, W.P.: Immunological mechanism for spontaneous abortion in systemic lupus erythematosus. Lancet 2: 1205–1207, 1977.CrossRefGoogle Scholar
  82. Brodsky, I., Baren, M., Kahn, S.B., Lewis, G., and Tellem, M.: Metastatic malignant melanoma from mother to fetus. Cancer 18: 1048–1054, 1965.PubMedCrossRefGoogle Scholar
  83. Brosens, I., and Renaer, M.: On the pathogenesis of placental infarcts in pre-eclampsia. J. Obstet. Gynaecol. Br. Commonw. 79: 794–799, 1972.PubMedCrossRefGoogle Scholar
  84. Brosens, I., Robertson, W.B., and Dixon, H.G.: The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93: 569–579, 1967.PubMedCrossRefGoogle Scholar
  85. Brosens, I.A., Robertson, W.B., and Dixon, H.G.: The role of the spiral arteries in the pathogenesis of preeclampsia. In, Obstetrics and Gynecology Annual: 1972. Vol. 1. R.M. Wynn, ed., pp. 177–191. Appleton-Century-Crofts, East Norwalk, CT, 1972.Google Scholar
  86. Brosens, I., Dixon, H.G., and Robertson, W.B.: Prostaglandins and pre-eclampsia. Lancet 2: 412–413, 1974.PubMedCrossRefGoogle Scholar
  87. Brown, S., Merkow, A., Wiener, M., and Khajezadeh, J.: Low birth weight in babies born to mothers with sickle cell trait. J.A.M.A. 221: 1404–1405, 1972.PubMedCrossRefGoogle Scholar
  88. Brownscheidele, C.M., and Davis, D.L.: Diabetes in pregnancy: a preliminary study of the pancreas, placenta and malformations in the BB Wistar rat. Placenta Suppl. 3: 203216, 1981.Google Scholar
  89. Bruner, J.P., Landon, M.B., and Gabbe, S.: Diabetes and Graves’ disease in pregnancy complicated by maternal allergies to antithyroid medication. Obstet. Gynecol. 72: 443–445, 1988.PubMedGoogle Scholar
  90. Buchanan, N.M.M., Khamashta, M.A., Morton, K.E., Kerslake, S., Baguley, E., and Hughes, G.R.V.: A study of 100 high risk lupus pregnancies. Am. J. Reprod. Immunol. 28: 192–194, 1992.PubMedGoogle Scholar
  91. Budliger, H.: Plazentarveränderungen and ihre Beziehung zur Spättoxikose and perinatalen kindlichen Sterblichkeit. Fortschr. Geburtshilfe Gynäkol. 17: 86–110, 1964.Google Scholar
  92. Buescher, M.A., McClamrock, H.D., and Adashi, E.Y.: Cushing syndrome in pregnancy: review. Obstet. Gynecol. 79: 130–137, 1992.PubMedGoogle Scholar
  93. Burrow, G.N., and Ferris, T.F.: Medical Complications During Pregnancy. Saunders & Harcourt Brace Jovanovich, Philadelphia, 1988.Google Scholar
  94. Burrows, D.A., O’Neil, T.J., and Sorrells, T.L.: Successful twin pregnancy after renal transplant maintained on cyclosporin A immunosuppression. Obstet. Gynecol. 72: 459461, 1988.Google Scholar
  95. Burstein, R., Berns, A.W., Hirata, Y., and Blumenthal, H.T.: A comparative histo-and immunopathological study of the placenta in diabetes mellitus and in erythroblastosis fetalis. Am. J. Obstet. Gynecol. 86: 66–76, 1963.PubMedGoogle Scholar
  96. Bylock, A., Bondjers, G., Jansson, I., and Hansson, H.-A.: Surface ultrastructure of human arteries with special reference to the effects of smoking. Acta Pathol. Microbiol. Scand. A 87: 201–209, 1979.Google Scholar
  97. Cameron, H.M., and Park, W.W.: Decidual tissue within the lung. J. Obstet. Gynaecol. Br. Commonw. 72: 748–754, 1965.PubMedCrossRefGoogle Scholar
  98. Campbell, W.A.: Fetal malignant melanoma: ultrasound presentation and review of the literature. Obstet. Gynecol. 70: 434–439, 1987.PubMedGoogle Scholar
  99. Cannon, J.F.: Pregnancy and pheochromocytoma. Obstet. Gynecol. 11: 43–48, 1958.PubMedGoogle Scholar
  100. Cardwell, M.S.: Ultrasound diagnosis of abruptio placentae with fetomaternal hemorrhage. Am. J. Obstet. Gynecol. 157: 358–359, 1987.PubMedGoogle Scholar
  101. Cariou, R., Tobelem, G., Soria, C., and Caen, J.: Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N. Engl. J. Med. 314: 1193–1194, 1986.PubMedCrossRefGoogle Scholar
  102. Carp, H.J.A., Frenkel, Y., Many, A., Menashe, Y., Mashiach, S., Nebel, L., Toder, V., and Serr, D.M.: Fetal demise associated with lupus anticoagulant: clinical features and results of treatment. Gynecol. Obstet. Invest. 28: 178184, 1989.Google Scholar
  103. Carreras, L.O., Defreyn, G., Machin, S.J., Vermylen, J., Deman, R., Spitz, B., and Assche, A.v.: Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1: 244–246, 1981a.PubMedCrossRefGoogle Scholar
  104. Carreras, L.O., Vermylen, J., Spitz, B., and Assche, A.v.: “Lupus” anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br. J. Obstet. Gynaecol. 88: 890–894, 1981b.PubMedCrossRefGoogle Scholar
  105. Carreras, L.O., Perez, G.N., Vega, H.R., and Casavilla, F.: Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 2: 393–394, 1988.PubMedCrossRefGoogle Scholar
  106. Carter, B.: Premature separation of the normally implanted placenta: six deaths due to gross bilateral cortical necrosis of the kidneys. Obstet. Gynecol. 29: 30–33, 1967.PubMedGoogle Scholar
  107. Carter, J.E., Vellios, F., and Huber, C.P.: Circulatory factors governing the viability of the human placenta, based on a morphologic study. Am. J. Clin. Pathol. 40: 363–373, 1963a.PubMedGoogle Scholar
  108. Carter, J.E., Vellios, F., and Huber, C.P.: Histologic classification and incidence of circulatory lesions of the human placenta, with a review of the literature. Am. J. Clin. Pathol. 40: 374–378, 1963b.Google Scholar
  109. Cavanagh, D., Rao, P.S., Tung, K.S.K., and Gastoni L.: Eclamptogenic toxemia: the development of an experimental model in the subhuman primate. Am. J. Obstet.Google Scholar
  110. Gynecol. 120:183–196, 1974.Google Scholar
  111. Cavanagh, D., Rao, P.S., Tsai, C.C., and O’Connor, T.C.: Experimental toxemia in the pregnant primate. Am. J. Obstet. Gynecol. 128: 75–85, 1977.PubMedGoogle Scholar
  112. Cavanagh, D., Rao, P.S., Knuppel, R.A., Desai, U., and Balis, J.U.: Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am. J. Obstet. Gynecol. 151: 987–999, 1985.PubMedGoogle Scholar
  113. Cavell, B.: Transplacental metastasis of malignant melanoma:report of a case. Acta Paediatr. Suppl. 146: 37–40, 1963.Google Scholar
  114. Chalmers, I.: Salt, pregnancy, hypertension—and literature searches. Lancet 2: 11–46, 1988.Google Scholar
  115. Chasnoff, I.J., Burns, W.J., Schnoll, S.H., and Burns, K.A.: Cocaine use in pregnancy. N. Engl. J. Med. 313: 666–669, 1985.PubMedCrossRefGoogle Scholar
  116. Chasnoff, I.J., Bussey, M.E., Savich, R., and Stack, C.M.: Perinatal cerebral infarction and maternal cocaine use. J. Pediatr. 108: 210–213, 1986.Google Scholar
  117. Chasnoff, I.J., Griffith, D.R., MacGregor, S., Dirkes, K., and Burns, K.A.: Temporal patterns of cocaine use in pregnancy: perinatal outcome. J.A.M.A. 261: 1741–1744, 1989.PubMedCrossRefGoogle Scholar
  118. Chasnoff, I.J., Landress, H.J., and Barrett, M.E.: The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N. Engl. J. Med. 322: 1202–1206, 1990.PubMedCrossRefGoogle Scholar
  119. Chavez, G.F., Mulinare, J., and Cordero, J.F.: Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. J.A.M.A. 262: 795–798, 1989.PubMedCrossRefGoogle Scholar
  120. Chen, Y., Pederson, L.L., and Lefcoe, N.M.: Passive smoking and low birthweight. Lancet 2: 54–55, 1989.PubMedCrossRefGoogle Scholar
  121. Chesley, L.C.: Diagnosis of preeclampsia. Obstet. Gynecol. 65: 423–425, 1985.PubMedGoogle Scholar
  122. Cheung, T.H., Leung, A., and Chang, A.: Macrosomic babies. Aust. N.Z. J. Obstet. Gynaecol. 30: 319–322, 1990.PubMedCrossRefGoogle Scholar
  123. Christianson, R.E.: Gross differences observed in the placentas of smokers and nonsmokers. Am. J. Epidemiol. 110: 178–187, 1979.PubMedGoogle Scholar
  124. Cibils, L.A.: The placenta and newborn infant in hypertensive conditions. Am. J. Obstet. Gynecol. 118: 256–268, 1974.PubMedGoogle Scholar
  125. Clarson, C., Tevaarwerk, G.J.M., Harding, P.G.R., Chance, G.W., and Haust, M.D.: Placental weight in diabetic pregnancies. Placenta 10: 275–281, 1989.PubMedCrossRefGoogle Scholar
  126. Coen, R.W., Papile, L.-A., Figueroa, R., and Henderson, V.M.: Infant survival following protracted fetoplacental separation. Pediatrics 53: 760–761, 1974.PubMedGoogle Scholar
  127. Combs, C.A., Easterling, T.R., Schmucker, B.C., and Benedetti, T.J.: Hemodynamic observations during paroxysmal hypertension in a pregnancy with a pheochromocytoma. Obstet. Gynecol. 74: 439–441, 1989.PubMedGoogle Scholar
  128. Combs, C.A., Katz, M.A., Kitzmiller, J.L., and Brescia, R.J.: Experimental preeclampsia of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am. J. Obstet. Gynecol. 169:215–223, 1993.Google Scholar
  129. Cove, D.H., and Johnson, P.: Fetal hyperthyroidism: experience of treatment in four siblings. Lancet 1: 430–432, 1985.PubMedCrossRefGoogle Scholar
  130. Covone, A.E., Mutton, D., Johnson, P.M., and Adinolfi, M.: Trophoblast cells in peripheral blood from pregnant women. Lancet 2: 841–843, 1984.PubMedCrossRefGoogle Scholar
  131. Cowchock, F.S., Reece, E.A., Balaban, D., Branch, D.W., and Plouffe, L.: Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol. 166: 1318–1323, 1992.PubMedGoogle Scholar
  132. Cramblett, H.G., Friedman, J.L., and Najjar, S.: Leukemia in an infant born of a mother with leukemia. N. Engl. J. Med. 259: 727–729, 1958.PubMedCrossRefGoogle Scholar
  133. Cregler, L.L., and Mark, H.: Medical complications of cocaine abuse. N. Engl. J. Med. 315: 1495–1500, 1986.PubMedCrossRefGoogle Scholar
  134. Cross, R.G., O’Connor, M.H., and Holland, P.J.: Placental metastasis of a breast carcinoma. J. Obstet. Gynaecol. Br. Emp. 58: 810–811, 1951.PubMedCrossRefGoogle Scholar
  135. Cruveiller, J., Harpey, J.-P., Vernon, P., Cannat, A., Delattre, A., Hervet, E., Lafourcade, J., and Turpin, R.: Lupus érythémateux systémique: transmission de manifestations cliniques et de facteurs biologiques de la mère au nouveu-né. Arch. Fr. Pediatr. 27: 195–209, 1970.PubMedGoogle Scholar
  136. Cunningham, F.G., and Lindheimer, M.D.: Hypertension in pregnancy. N. Engl. J. Med. 326: 927–932, 1992.PubMedCrossRefGoogle Scholar
  137. Cunningham, F.G., Lowe, T., Guss, S., and Mason, R.: Erythrocyte morphology in women with severe preeclampsia: preliminary observations with scanning electron microscopy. Am. J. Obstet. Gynecol. 153: 358–363, 1985.PubMedGoogle Scholar
  138. Dadak, C., Leithner, C., Sinzinger, H., and Silberbauer, K.: Diminished prostacyclin formation in umbilical arteries of babies born to women who smoke. Lancet 1: 94, 1981.PubMedCrossRefGoogle Scholar
  139. Daffos, F., Forester, F., and Kaplan, C.: Prenatal treatment of fetal alloimmune thrombocytopenia. Lancet 2: 910, 1988.CrossRefGoogle Scholar
  140. Dameshek, W.: Systemic lupus erythematosus: a complex auto-immune disorder ? Ann. Intern. Med. 48: 707–730, 1958.PubMedCrossRefGoogle Scholar
  141. Davey, D.A., and MacGillivray, I.: The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158: 892–898, 1988.PubMedGoogle Scholar
  142. Davey, D.A., and MacGillivray, I.: Classification of hypertensive disorders of pregnancy. Lancet 2: 112, 1989.CrossRefGoogle Scholar
  143. Davis, L.E., Leveno, K.J., and Cunningham, F.G.: Hypothyroidism complicating pregnancy. Obstet. Gynecol. 72: 108–112, 1988.PubMedGoogle Scholar
  144. Davis, L.E., Lucas, M.J., Hankins, G.D.V., Roark, M.L., and Cunningham, F.G.: Thyrotoxicosis complicating pregnancy. Am. J. Obstet. Gynecol. 160: 63–70, 1989.PubMedGoogle Scholar
  145. Davison, J.M.: Renal transplantation and pregnancy. Am. J. Kidney Dis. 9: 374–380, 1987.PubMedGoogle Scholar
  146. Deaver, J.E., Leppert, P.C., and Zaroulis, C.G.: Neonatal alloimmune thrombocytopenic purpura: a case report. Am. J. Obstet. Gynecol. 154: 153–155, 1986.PubMedGoogle Scholar
  147. Delerive, C., Locquet, F., Mallart, A., Janin, A., and Gosselin, B.: Placental metastasis from maternal bronchial oat cell carcinoma. Arch. Pathol. Lab. Med. 113: 556–558, 1989.PubMedGoogle Scholar
  148. Demers, L.M., and Gabbe, S.G.: Placental prostaglandin levels in pre-eclampsia. Am. J. Obstet. Gynecol. 126: 137139, 1976.Google Scholar
  149. Demian, S.D.E., Donnelly, W.H., Frias, J.L., and Monif, G.R.G.: Placental lesions in congenital giant pigmented nevi. Am. J. Clin. Pathol. 61: 438–442, 1974.PubMedGoogle Scholar
  150. De Wolf, F., Robertson, W.B., and Brosens, I.: The ultra-structure of acute atherosis in hypertensive pregnancy. Am. J. Obstet. Gynecol. 123: 164–174, 1975.PubMedGoogle Scholar
  151. De Wolf, F., Carreras, L.O., Moerman, P., Vermylen, J., von Assche, A., and Renaer, M.: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and lupus anticoagulant. Am. J. Obster. Gynecol. 142: 829–834, 1982.Google Scholar
  152. Diamandopoulos, G.T., and Hertig, A.T.: Transmission of leukemia and allied diseases from mother to fetus. Obstet. Gynecol. 21: 150–154, 1963.PubMedGoogle Scholar
  153. Dines, D.E., and Banner, E.A.: Sarcoidosis during pregnancy: improvement in pulmonary function. J.A.M.A. 200: 726–727, 1967.PubMedCrossRefGoogle Scholar
  154. Ditts, P.V.: Placental transfer of ethanol. Am. J. Obstet. Gynecol. 112: 1195–1198, 1970.Google Scholar
  155. Dombrowski, M.P., Wolfe, H.M., Welch, R.A., and Evans, M.I.: Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor. Obstet. Gynecol. 77: 139–141, 1991.PubMedGoogle Scholar
  156. Donegan, W.L.: Cancer and pregnancy. CA 33: 194–214, 1983.Google Scholar
  157. Donvito, M.T.: Cocaine use during pregnancy: adverse perinatal outcome. Am. J. Obstet. Gynecol. 159: 786–787, 1988.Google Scholar
  158. Dreifuss, F.E., and McKinney,. W.M.: Wilson’s disease (hepatolenticular degeneration) and pregnancy. J.A.M.A. 195: 960–962, 1966.PubMedCrossRefGoogle Scholar
  159. Driscoll, S.G.: The pathology of pregnancy complicated by diabetes mellitus. Med. Clin. North Am. 49: 1053–1067, 1965.Google Scholar
  160. Driscoll, S.G., Hicks, S.P., Copenhaver, E.H., and Easterday, C.L.: Acute radiation injury in two human fetuses. Arch. Pathol. 76: 113–119, 1963.Google Scholar
  161. Druzin, M.L., Lockshin, M., Edersheim, T.G., Hutson, J.M., Krauss, A.L., and Kogut, E.: Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. Am. J. Obstet. Gynecol. 157: 1503–1510, 1987.PubMedGoogle Scholar
  162. Ducey, J., Schulman, H., Farmakides, G., Rochelson, B., Bracero, L., Fleischer, A., Guzman, E., Winter, D., and Penny, B.: A classification of hypertension in pregnancy based on Doppler velocimetry. Am. J. Obstet. Gynecol. 157: 680–685, 1987.PubMedGoogle Scholar
  163. Duhring, J.L.: Pregnancy, rheumatoid arthritis, and intrauterine growth retardation. Am. J. Obstet. Gynecol. 108: 325–326, 1970.PubMedGoogle Scholar
  164. Dunlop, W., Hill, L.M., Landon, M.J., Oxley, A., and Jones, P.: Clinical relevance of coagulation and renal changes in pre-eclampsia. Lancet 2: 346–349, 1978.PubMedCrossRefGoogle Scholar
  165. Dyer, I., and McCaughey, E.V.: Abruptio placentae: a ten-year survey. Am. J. Obstet. Gynecol. 77: 1176–1184, 1959.PubMedGoogle Scholar
  166. Easterling, T.R., and Benedetti, T.J.: Preeclampsia: a hyper-dynamic disease model. Am. J. Obstet. Gynecol. 160: 1447 1453, 1989.Google Scholar
  167. Easterling, T.R., Chadwick, H.S., Otto, C.M., and Benedetti, T.J.: Aortic stenosis in pregnancy. Obstet. Gynecol. 72: 113–118, 1988.PubMedGoogle Scholar
  168. Editorial: Smoking during pregnancy. B.M.J. 2: 339–340, 1968.Google Scholar
  169. Editorial: Systemic lupus erythematosus in pregnancy. Lancet 338: 87–88, 1991.CrossRefGoogle Scholar
  170. Edson, J.R., Blaese, R.M., White, J.G., and Krivit, W.: Defibrination syndrome in an infant born after abruptio placentae. Am. J. Obstet. Gynecol. 72: 342–346, 1968.Google Scholar
  171. Elkind-Hirsch, K.E., Raynolds, M.V., and Goldzieher, J.W.: Comparison of immunoreactive gonadotropin-releasing hormone and human chorionic gonadotropin in term placentas from normal women and those with insulin-dependent and gestational diabetes. Am. J. Obstet. Gynecol. 160: 71–78, 1989.PubMedGoogle Scholar
  172. El-Roeiy, A., Myers, S.A., and Gleicher, N.: The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet. Gynecol. 75: 390–396, 1990.PubMedGoogle Scholar
  173. Elsas, L.J., Whittemore, R., and Burrow, G.N.: Maternal and neonatal Graves’ disease. J.A.M.A. 200: 250–252, 1967.PubMedCrossRefGoogle Scholar
  174. Emmrich, P., Amendt, P., and Gödel, E.: Morphologie der Plazenta and neonatale Acidose bei mütterlichem Diabetes mellitus. Pathol. Microbiol. 40: 100–114, 1974.Google Scholar
  175. Epstein, F.H.: Late vascular effects of toxemia of pregnancy. N. Engl. J. Med. 271: 391–395, 1964.PubMedCrossRefGoogle Scholar
  176. Erskine, K.J., Iversen, S.A., and Davies, R.: An altered ratio of 18:2(9,11) to 18:2(9,12) linoleic acid in plasma phospholipids as a possible predictor of pre-eclampsia. Lancet 1: 554–555, 1985.PubMedCrossRefGoogle Scholar
  177. Fadel, H.E., and Krauss, J.S.: Factor VII deficiency and pregnancy. Obstet. Gynecol. 73: 453–454, 1989.PubMedGoogle Scholar
  178. Farquharson, R.G., Compston, A., and Bloom, A.L.: Lupus anticoagulant: a place for pre-pregnancy treatment? Lancet 2: 842–843, 1985.PubMedCrossRefGoogle Scholar
  179. Feinstein, D.I.: Lupus anticoagulant, thrombosis, and fetal loss. N. Engl. J. Med. 313: 1348–1350, 1985.PubMedCrossRefGoogle Scholar
  180. Feraboli, M.: La placenta nelle cardiopatie. Quad. Clin. Ostet. Ginecol. (Genoa) 6: 219–230, 1951.Google Scholar
  181. Fiddler, G.I.: Propranolol and pregnancy. Lancet 2: 722–723, 1974.PubMedCrossRefGoogle Scholar
  182. Fischer, U., and Horky, Z.: Vorläufige Untersuchungen zum Glykogengehalt sowie Sauerstoff-and Glukoseverbrauch der Plazenta in vitro bei Diabetes mellitus. In, Schwangerschaft and Neugeborenes der Zuckerkranken Frau. (IV. Intern. Symp. Diabetesfragen). G. Mohnike, ed., pp. 82–88. VEB Verlag Volk u. Gesundheit, Berlin, 1966.Google Scholar
  183. Fisk, N.M., and Storey, G.N.B.: Fetal outcome in obstetric cholestasis. Br. J. Obstet. Gynaecol. 95: 1137–1143, 1988.PubMedCrossRefGoogle Scholar
  184. Fitzgerald, D.J., Rocki, W., Murray, R., Mayo, G., and Fitzgerald G.A.: Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335: 751–754, 1990.PubMedCrossRefGoogle Scholar
  185. Fox, H.: White infarcts of the placenta. J. Obstet. Gynaecol. Br. Commonw. 70: 980–991, 1963.PubMedCrossRefGoogle Scholar
  186. Fox, H.: Pathology of the placenta in maternal diabetes mellitus. Obstet. Gynecol. 34: 792–798, 1969.PubMedGoogle Scholar
  187. Fox, H.: Effect of hypoxia on trophoblast in organ culture. Am. J. Obstet. Gynecol. 107: 1058–1064, 1970.PubMedGoogle Scholar
  188. Fox, H.: Pathology of the Placenta. Saunders, London, 1978.Google Scholar
  189. Fox, L.P., Grandi, J., Johnson, A.H., Watrous, W.G., and Johnson, M.J.: Pheochromocytoma associated with pregnancy. Am. J. Obstet. Gynecol. 104: 288–294, 1969.PubMedGoogle Scholar
  190. Frank, D.A., Zuckerman, B.S., Amaro, H., Aboagye, K., Bauchner, H., Cabral, H., Fried, L., Hingson, R., Kayne, H., Levenson, S.M., Parker, S., Reece, H., and Vinci, R.: Cocaine use during pregnancy: prevalence and correlates. Pediatrics 82: 888–895, 1988.PubMedGoogle Scholar
  191. Freedman, W.L., and McMahon, F.J.: Placental metastasis: review of the literature and report of a case of metastatic melanoma. Obstet. Gynecol. 16: 550–560, 1960.PubMedGoogle Scholar
  192. Freese, U.E.: A placental evaluation of drug addiction in pregnancy. J. Reprod. Med. 20: 307–315, 1978.PubMedGoogle Scholar
  193. Friedman, S.A.: Preeclampsia: a review of the role of Prostaglandins. Obstet. Gynecol. 71: 122–137, 1988.PubMedGoogle Scholar
  194. Fujikura, T., and Froehlich, L.: Diagnosis of sickling by placental examination. Am. J. Obstet. Gynecol. 100: 1122 1124, 1968.Google Scholar
  195. Fulroth, R., Phillips, B., and Durand, D.J.: Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am. J. Dis. Child. 143: 905–910, 1989.PubMedGoogle Scholar
  196. Gau, G.S., Bhundia, J., Napier, K., and Ryder, T.A.: The worm that wasn’t. Lancet 1: 1160–1161, 1983.PubMedCrossRefGoogle Scholar
  197. George, P.A., Fortner, J.G., and Pack, G.T.: Melanoma with pregnancy: a report of 115 cases. Cancer 13: 854–859, 1960.PubMedCrossRefGoogle Scholar
  198. Gerretsen, G., Huisjes, H.J., and Elema, J.D.: Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br. J. Obstet. Gynaecol. 88: 876–881, 1981.PubMedCrossRefGoogle Scholar
  199. Gerretsen, G., Huisjes, H.J., Hardonk, M.J., and Elema, J.D.: Trophoblastic alterations in the placental bed in relation to physiological changes in spiral arteries. Br. J. Obstet. Gynaecol. 90: 34–39, 1983.PubMedCrossRefGoogle Scholar
  200. Gilbert, W.M., Lafferty, C.M., Benirschke, K., and Resnik, R.: Lack of specific placental abnormality associated with cocaine use. Am. J. Obstet. Gynecol. 163: 998–999, 1990.PubMedGoogle Scholar
  201. Giles, W.B., Trudinger, B.J., and Baird, P.J.: Fetal umbilical artery blood flow velocity waveforms and placental resistance: pathological correlation. Br. J. Obstet. Gynaecol. 92: 31–35, 1985.PubMedCrossRefGoogle Scholar
  202. Gille, J.H., Moore, D.G., and Sedgwick, C.J.: Placental infarction: a sign of preeclampsia in a Patas monkey (Erythrocebus patas). Lab. Anim Sci. 27: 120–121, 1977.Google Scholar
  203. Ginsberg, J., and Jeacock, M.K.: Placental lactate production in toxemia of pregnancy. Am. J. Obstet. Gynecol. 98: 239244, 1967.Google Scholar
  204. Gitlin, D., Kumate, J., and Morales, C.: Placental insulin transport. Pediatrics 33: 65–69, 1965.Google Scholar
  205. Gleicher, N., and Friberg, J.: IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. J.A.M.A. 253: 3278–3281, 1985.PubMedCrossRefGoogle Scholar
  206. Goldstein, D.P., and Berkowitz, R.S.: Single-agent chemotherapy. In, Gestational Trophoblastic Disease. A.E. Szulman and H.J. Buchsbaum, eds., pp. 135–145. Springer-Verlag, New York, 1987.Google Scholar
  207. Goodlin, R.C., Anderson, J.C., and Skiles, T.L.: Pruritus and hyperplacentosis. Obstet. Gynecol. 66: 36S - 38S, 1985.PubMedGoogle Scholar
  208. Goodman, R.M., Gresham, G.E., and Roberts, P.L.: Outcome of pregnancy in patients with hereditary hemorrhagic telangiectasia: a retrospective study of 40 patients and 80 matched controls. Fertil. Steril. 18: 272–277, 1967.PubMedGoogle Scholar
  209. Gött, E.: Lupus erythematodes disseminatus: Schwangerschaft and Geburt. Dtsch. Med. Wochenschr. 94: 274–279, 1969.PubMedCrossRefGoogle Scholar
  210. Goujard, J., Rumeau, E., and Schwartz, D.: Smoking during pregnancy, stillbirth and abruptio placentae. Biomedicine 23: 20–22, 1975.PubMedGoogle Scholar
  211. Goujard, J., Kaminski, M., Rumeau-Rouquette, C., and Schwartz, D.: Maternal smoking, alcohol consumption, and abruptio placenta [letter to the editor]. Am. J. Obstet. Gynecol. 130: 738–739, 1978.PubMedGoogle Scholar
  212. Greco, M.A., Klein, S., and Bigelow, B.: Lymphocytosis in the first-trimester placenta of a mother taking diphenylhydantoin. N. Engl. J. Med. 289: 867–868, 1973.PubMedGoogle Scholar
  213. Greco, M.A., Kamat, B.R., and Demopoulos, R.I.: Placental protein distribution in maternal diabetes mellitus: an immunocytochemical study. Pediatr. Pathol. 9: 679–690, 1989.PubMedCrossRefGoogle Scholar
  214. Grennan, D.M., McCormick, J.N., Wojtacha, D., Carty, M., and Behan, W.: Immunological studies of the placenta in systemic lupus erythematosus. Ann. Rheum. Dis. 37: 129134, 1978.Google Scholar
  215. Griffin, J.F.T., and Wilson, E.W.: Pre-eclampsia: a state of mother-fetus immune imbalance. Lancet 2: 1366–1367, 1979.PubMedCrossRefGoogle Scholar
  216. Grimes, E.M., Fayez, J.A., and Miller, G.L.: Cushing’s syndrome and pregnancy. Obstet. Gynecol. 42: 550–559, 1973.PubMedCrossRefGoogle Scholar
  217. Grimes, D.A., LeBolt, S.A., Grimes, K.R., and Wingo, P.A.: Systemic lupus erythematosus and reproductive function: a case-control study. Am. J. Obstet. Gynecol. 153: 179–186, 1985.PubMedGoogle Scholar
  218. Grimmer, D., Landas, S., and Kemp, J.D.: IgM antitrophoblast antibodies in a patient with a pregnancy-associated lupuslike disorder, vasculitis, and recurrent intrauterine fetal demise. Arch. Pathol. Lab. Med. 112: 191–193, 1988.PubMedGoogle Scholar
  219. Grossman, R.A., and Goldberg, E.H.: Incidence and recurrence rate of abruptio placentae in Sweden. Obstet. Gynecol. 69: 280–281, 1987.PubMedGoogle Scholar
  220. Gruenwald, P., Levin, H., and Yousem, H.: Abruption and premature separation of the placenta. Am. J. Obstet. Gynecol. 102: 604–610, 1968.PubMedGoogle Scholar
  221. Gunther, R., and Harer, W.: Systemic scleroderma and pregnancy. Obstet. Gynecol. 23: 297–300, 1964.Google Scholar
  222. Gusdon, J.P., Heise, E.R., and Herbst, G.A.: Studies of lymphocyte populations in pre-eclampsia-eclampsia. Am. J. Obstet. Gynecol. 129: 255–259, 1977.PubMedGoogle Scholar
  223. Gusdon, J.P., Heise, E.R., Quinn, K.J., and Matthews, L.C.: Lymphocyte subpopulations in normal and preeclampsia pregnancies. Am. J. Reprod. Immunol. 5: 28–31, 1984.PubMedGoogle Scholar
  224. Haile, H.: Über Schädigung des Neugeborenen bei Eklampsie. Z. Geburtshilfe Gynäkol. 120: 334–352, 1940.Google Scholar
  225. Halberstadt, E., Schneider, D., and Gerber, E.: Über die vorzeitige Lösung der normal inserierten Placenta. Gynaecologia 167: 491–502, 1969.PubMedGoogle Scholar
  226. Handin, R.I.: Neonatal immune thrombocytopenia—the doctor’s dilemma. N. Engl. J. Med. 305: 951–953, 1981.PubMedCrossRefGoogle Scholar
  227. Hanretti, K.P., Whittle, M.J., and Rubin, P.C.: Doppler uteroplacental waveforms in pregnancy-induced hypertension: a re-appraisal. Lancet 1: 850–852, 1988.CrossRefGoogle Scholar
  228. Haour, F., and Bertrand, J.: Insulin receptors in the plasma membranes of human placenta. J. Clin. Endocrinol. Metab. 38: 334–337, 1974.PubMedCrossRefGoogle Scholar
  229. Harris, B.A., Gore, H., and Flowers, C.E.: Peripheral placental separation: A possible relationship to premature labor. Obstet. Gynecol. 66: 774–778, 1985.PubMedGoogle Scholar
  230. Haupt, H.: Über das Schocksyndrom des Neugeborenen nach vorzeitiger Plazentalösung. Munch. Med. Wochenschr. 105: 441–449, 1963.PubMedGoogle Scholar
  231. Haust, M.D.: Maternal diabetes mellitus—effects on the fetus and placenta. In, Perinatal Diseases. R.L. Naeye, J.M. Kissane, and N. Kaufman eds., pp. 201–285. Williams & Wilkins, Baltimore, 1981.Google Scholar
  232. Haust, M.D., Heras, J.L., and Harding, P.G.: Fat-containing uterine smooth muscle cells in “toxemia”: possible relevance to atherosclerosis? Science 195: 1353–1354, 1977.PubMedCrossRefGoogle Scholar
  233. Hayes, G.W., Walsh, C.R., and d’Alessandro, E.E.: Scleroderma in pregnancy: report of a case. Obstet. Gynecol. 19: 273–274, 1962.PubMedGoogle Scholar
  234. Haynes, D.M.: Experimental abruptio placentae in the rabbit. Am. J. Obstet. Gynecol. 85: 626–645, 1963.PubMedGoogle Scholar
  235. Hayslett, J.P., and Reece, E.A.: Systemic lupus erythematosus in pregnancy. Clin. Perinatol. 12: 539–549, 1985.PubMedGoogle Scholar
  236. Heite, H.-J., and Kaden, G.: Metastasierung bösartiger Tumoren, insbesondere des malignen Melanomas, in Plazenta and Kind. Munch. Med. Wochenschr. 114:19091913, 1972.Google Scholar
  237. Hennessey, J.P., and Rottino, A.: Hodgkin’s disease in pregnancy. Am. J. Obstet. Gynecol. 87: 851–853, 1963.Google Scholar
  238. Hertig, A.T.: Vascular pathology in hypertensive albuminuric toxemias of pregnancy. Clinics 4: 602–614, 1945.Google Scholar
  239. Hibbard, B.M., and Hibbard, E.D.: Aetiological factors in abruptio placentae. B.M.J. 2: 1430–1436, 1963.CrossRefGoogle Scholar
  240. Hibbard, B.M., and Hibbard, E.D.: Folate metabolism and reproduction. Br. Med. Bull. 24: 10–14, 1968.Google Scholar
  241. Higgins, S.D., and Garite, T.J.: Late abruptio placenta in trauma patients: implications for monitoring. Obstet. Gynecol. 63: 10S - 12S, 1984.PubMedGoogle Scholar
  242. Hill, J.G., and Brunton, F.J.: Arteriographic assessment of placental vascularity after antepartum haemorrhage. B.M.J. 1: 25–26, 1968.CrossRefGoogle Scholar
  243. Hodari, A.A.: Chronic uterine ischemia and reversible experimental “toxemia of pregnancy. ” Am. J. Obstet. Gynecol. 97: 597–607, 1967.PubMedGoogle Scholar
  244. Hoet, J.-P., de Meyer, R., and de Meyer-Doyen, L.: Hypothyroïdie et grossesse. Heiv. Med. Acta 27: 178–195, 1960.Google Scholar
  245. Hoff, C., and Bixler, C.: Maternofetal ABO antigenic dissimilarity and preeclampsia. Lancet 1: 729–730, 1984.PubMedCrossRefGoogle Scholar
  246. Holaday, W.J., and Castrow, F.F.: Placental metastasis from a fetal giant pigmented nevus. Arch. Dermatol. 98: 486–488, 1968.PubMedCrossRefGoogle Scholar
  247. Holland, E.: A case of transplacental metastasis of malignant melanoma from mother to foetus. J. Obstet. Gynaecol. Br. Emp. 56: 529–538, 1949.PubMedCrossRefGoogle Scholar
  248. Hollister, M.C., Reid, D.L., Phernetton, T.M., Landauer, M., and Rankin, J.H.G.: Dose-response curves of the uterine and placental vascular beds to prostaglandin I2. Am. J. Obstet. Gynecol. 159: 1372–1375, 1988.PubMedGoogle Scholar
  249. Holmes, R.W.: Ablatio placentae. J.A.M.A. 51: 1845–1848, 1908.CrossRefGoogle Scholar
  250. Hölzl, M., Lüthje, D., and Seck-Ebersbach, K.: Placentaveränderungen bei EPH-Gestose: morphologischer Befund and Schweregrad der Erkrankung. Arch. Gynecol. 217: 315–334, 1974.Google Scholar
  251. Honoré, L.H., and Brown, L.B.: Intervillous placental metastasis with maternal myeloid leukemia. Arch. Pathol. Lab. Med. 114: 450, 1990.PubMedGoogle Scholar
  252. Horky, Z.: Angiolopathia myometrii bei Diabetes mellitus. Geburtshilfe Frauenheilkd. 28: 674–679, 1968.PubMedGoogle Scholar
  253. Hörmann, G., and Lemtis, H.: Abwehrleistungen der “Einheit Fetus and Plazenta” gegenüber hämatogen verschleppten Zellverbänden maligner Blastome der Mutter. Z. Geburtshilfe Gynäkol. 164: 129–142, 1965a.PubMedGoogle Scholar
  254. Hörmann, G., and Lemtis, H.: Zur Frage der diaplazentaren Metastasierung maligner Blastome der Mutter. Z. Geburtshilfe Gynäkol. 164: 1–8, 1965b.PubMedGoogle Scholar
  255. Homer, E.N.: Placental metastases: case report: maternal death from ovarian cancer. Obstet. Gynecol. 15: 566–572, 1960.Google Scholar
  256. Hoskins, I.A., Friedman, D.M., Frieden, F.J., Ordorica, S.A., and Young, B.K.: Relationship between antepartum cocaine abuse, abnormal umbilical artery doppler velocimetry, and placental abruption. Obstet. Gynecol. 78: 279–282, 1991.PubMedGoogle Scholar
  257. Hou, S.: Pregnancy in women with chronic renal disease. N. Engl. J. Med. 312: 836–839, 1985.PubMedCrossRefGoogle Scholar
  258. Houlton, M.C.C., and Jackson, M.B.A.: Gaucher’s disease and pregnancy. Obstet. Gynecol. 51: 619–620, 1978.PubMedCrossRefGoogle Scholar
  259. Houwert-De Jong, M.H., te Velde, E.R., Nefkens, M.J.J., and Schuurman, H.J.: Immune complexes in skin of patients with pre-eclamptic toxaemia. Lancet 2: 387, 1982.CrossRefGoogle Scholar
  260. Howard, B.K., and Goodson, J.H.: Experimental placental abruption. Obstet. Gynecol. 2: 442–446, 1953.PubMedGoogle Scholar
  261. Howard, R.B., Hosokawa, T., and Maguire, M.H.: Hypoxiainduced fetoplacental vasoconstriction in perfused human placental cotyledons. Am. J. Obstet. Gynecol. 157: 1261 1266, 1987.Google Scholar
  262. Huber, C.P., Carter, J.E., and Vellios, F.: Lesions of the circulatory system of the placenta: a study of 234 placentas with special reference to the development of infarcts. Am. J. Obstet. Gynecol. 81: 560–573, 1961.PubMedGoogle Scholar
  263. Hulka, J.F.: Discussion of Grimes et al. Am. J. Obstet. Gynecol. 153: 185, 1985.Google Scholar
  264. Hulka, J.F., and Brinton, V.: Antibody to trophoblast during early postpartum period in toxemic pregnancies. Am. J. Obstet. Gynecol. 86: 130–134, 1963.PubMedGoogle Scholar
  265. Hull, D., Binns, B.A.O., and Joyce, D.: Congenital heart block and widespread fibrosis due to maternal lupus erythematosus. Arch. Dis. Child. 41: 688–690, 1966.PubMedCrossRefGoogle Scholar
  266. Hunter, C.A., Howard, W.F., and McCormick, C.O.: Postpartum curettage effective in reducing hypertension of toxemia. Am. J. Obstet. Gynecol. 81: 884–889, 1961.PubMedGoogle Scholar
  267. Iklé, A.: Trophoblastzellen im strömenden Blut. Schweiz. Med. Wochenschr. 91: 943, 1961.PubMedGoogle Scholar
  268. Iklé, F.A.: Dissemination von Syncytiotrophoblastzellen im mütterlichen Blut während der Gravidität. Bull. Schweiz. Akad. Med. Wiss. 20: 63–72, 1964.Google Scholar
  269. Infante-Rivard, C., David, M., Gauthier, R., and Rivard, G.E.: Lupus anticoagulants, anticardiolipin antibodies, and fetal loss: a case-control study. N. Engl. J. Med. 325: 1063 1066, 1991.Google Scholar
  270. Jäämeri, K.E.U., Koivuniemi, A.P., and Carpén, E.O.: Occurrence of trophoblasts in the blood of toxaemic patients. Gynaecologia 160: 315–320, 1965.PubMedGoogle Scholar
  271. Jackson, R.: Discoid lupus in a newborn infant of a mother with lupus erythematosus. Pediatrics 33: 425–430, 1964.PubMedGoogle Scholar
  272. Jackson, M.R., Mayhew, T.M., and Haas, J.D.: Morpho-metric studies on villi in human term placentae and the effects of altitude, ethnic grouping and sex of newborn. Placenta 8: 487–495, 1987.PubMedCrossRefGoogle Scholar
  273. Jackson, M.R., Mayhew, T.M., and Haas, J.D.: Effects of high altitude on the vascularization of terminal villi in human placentae. In, Trophoblast Research, Vol. 3. P. Kaufmann and R.K. Miller, eds., pp. 351–360, Plenum, New York, 1988.Google Scholar
  274. Jâcomo, K.H., Benedetti, W.L., Sala, M.A., and Alvarez, H.: Pathology of the trophoblast and fetal vessels of the placenta in maternal diabetes mellitus. Acta Diabetol. Lat. 13: 216–235, 1976.Google Scholar
  275. James, R.F.: Snake bite in pregnancy. Lancet 2: 731, 1985.PubMedCrossRefGoogle Scholar
  276. Jauniaux, E., and Burton, G.J.: The effect of smoking in pregnancy on early placental morphology. Obstet. Gynecol. 79: 645–648, 1992.PubMedGoogle Scholar
  277. Javert, C.T., and Reiss, C.: The origin and significance of macroscopic intervillous coagulation hematomas (red infarcts) of the human placenta. Surg. Gynecol. Obstet. 94: 257–269, 1952.PubMedGoogle Scholar
  278. Jeremy, J.Y., Barradas, M.A., Mikhailidis, D.P., and Dandona, P.: Placental prostaglandin production in normal and toxemic pregnancies (letter). Amer. J. Obstet. Gynecol. 154: 212–214, 1986.Google Scholar
  279. Johnson, F.D.: Pregnancy and concurrent chronic myelogenous leukemia. Am. J. Obstet. Gynecol. 112: 640–644, 1972.PubMedGoogle Scholar
  280. Johnson, P.M., Natvig, J.B., Ystehede, U.A., and Faulk, W.P.: Immunological studies on human placentae: the distribution and character of immunoglobulins in chorionic villi. Clin. Exp. Immunol. 30: 145–153, 1977.PubMedGoogle Scholar
  281. Jones, C.J.P., and Fox, H.: Placental changes in gestational diabetes: an ultrastructural study. Obstet. Gynecol. 48: 274280, 1976.Google Scholar
  282. Jones, C.J.P., and Fox, H.: An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1: 61–76, 1980.PubMedCrossRefGoogle Scholar
  283. Jones, E.M.: Placental metastases from bronchial carcinoma. B.M.J. 1: 491–492, 1969.CrossRefGoogle Scholar
  284. Jones, K.L., Smith, D.W., Ulleland, C.N., and Streissguth, A.P.: Pattern of malformation in offspring of chronic alcoholic women. Lancet 1: 1267–1271, 1973.PubMedCrossRefGoogle Scholar
  285. Jones, T.G., Goldsmith, K.L.G., and Anderson, I.M.: Maternal and neonatal platelet antibodies in a case of congenital thrombocytopenia. Lancet 2: 1008–1009, 1961.PubMedCrossRefGoogle Scholar
  286. Jorgensen, K.R., Deckert, T., Pedersen, L.M., and Pedersen, J.: Insulin, insulin antibody and glucose in plasma of newborn infants of diabetic women. Acta Endocrinol. (Copenh.) 52: 154–167, 1966.Google Scholar
  287. Jung, A.L., Roan, Y., and Temple, A.R.: Neonatal death associated with transplacental ethanol intoxication. Am. J. Dis. Child. 134: 419–420, 1980.PubMedGoogle Scholar
  288. Kaibara, M., Kobayashi, T., and Matsumoto, S.: Idiopathic thrombocythemia and pregnancy: report of a case. Obstet. Gynecol. 65: 18S - 19S, 1985.PubMedGoogle Scholar
  289. Kalhan, S.C., Schwartz, R., and Adam, P.A.J.: Placental barrier to human insulin-I125 in insulin-dependent diabetic mothers. J. Clin. Endocrinol. Metab. 40: 139–142, 1975.PubMedCrossRefGoogle Scholar
  290. Kaminski, M., Rumeau-Rouquette, C., and Schwartz, D.: Effects of alcohol on the fetus. N. Engl. J. Med. 298: 55–56, 1978.Google Scholar
  291. Kaplan, M.M.: Acute fatty liver of pregnancy. N. Engl. J. Med. 313: 367–370, 1985.PubMedCrossRefGoogle Scholar
  292. Kaplan, C., Daffos, F., Forestier, F., Tertian, G., Catherine, N., Pons, J.C., and Tchernia, G.: Fetal platelet counts in thrombocytopenic pregnancy. Lancet 336: 979–982, 1990.PubMedCrossRefGoogle Scholar
  293. Karegârd, M., and Gennser, G.: Incidence and recurrence rate of abruptio placentae in Sweden. Obstet. Gynecol. 67: 523–528, 1986.PubMedGoogle Scholar
  294. Kaufmann, P., and Stark, J.: Ultrastruktur der Plazenta bei Diabetes, EPH-Gestose und Rh-Inkompatibilität. In, Neue Erkenntnisse über die Orthologie und Pathologie der Plazenta. J.J. Födisch, ed., pp. 53–62. Ferdinand Enke Verlag, Stuttgart, 1977.Google Scholar
  295. Kaufmann, P., Kohnen, G., and Kosanke, G.: Wechselwirkungen zwischen Plazentamorphologie und fetaler Sauerstoffversorgung: Versuch einer zellbiologischen Interpretation pathohistologischer and experimenteller Befunde. Gynäkologe 26: 16–23, 1993.PubMedGoogle Scholar
  296. Kelemen, J.T., and Mandi, L.: Sarcoidose in der Placenta. Zentralbl. Allg. Pathol. 112: 18–21, 1969.PubMedGoogle Scholar
  297. Kerber, I.J., Warr, O.S., and Richardson, C.: Pregnancy in a patient with a prosthetic mitral valve: associated with a fetal anomaly attributed to Warfarin sodium. J.A.M.A. 203: 223–225, 1968.PubMedCrossRefGoogle Scholar
  298. Khong, T Y: Immunohistologic study of the leukocytic infiltrate in maternal uterine tissues in normal and preeclamptic pregnancies at term. Am. J. Reprod Immunol. 15: 1–8, 1987.Google Scholar
  299. Khong, T.Y., Pearce, J.M., and Robertson, W.B.: Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion. Am. J. Obstet. Gynecol. 157: 360–363, 1987.PubMedGoogle Scholar
  300. Khong, T.Y., Sawyer, I.H., and Heryet, A.: An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy: evidence that endothelium is focally disrupted by trophoblast in preeclampsia. Am. J. Obstet. Gynecol. 167: 751–756, 1992.PubMedGoogle Scholar
  301. Kilpatrick, D.C.: Immune mechanisms and pre-eclampsia. Lancet 2: 1460–1461, 1987.PubMedCrossRefGoogle Scholar
  302. Kimmerle, R., and Chantelau, E.A.: Transplacental passage of insulin. N. Engl. J. Med. 324: 198–199, 1991.CrossRefGoogle Scholar
  303. Kirshon, B., Edwards, J., and Cotton, D.B.: Gordon’s syndrome in pregnancy. Am. J. Obstet. Gynecol. 156: 1110–1111, 1987.PubMedGoogle Scholar
  304. Kitay, D.Z.: Folic acid in pregnancy. J.A.M.A. 204: 79, 1968.PubMedCrossRefGoogle Scholar
  305. Kitzmiller, J.L., and Benirschke, K.: Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy. Am. J. Obstet. Gynecol. 115: 248–251, 1973.PubMedGoogle Scholar
  306. Kitzmiller, J.L., Stoneburner, L., Yelenovsky, P.F., and Lucas, W.E.: Serum complement in normal pregnancy and pre-eclampsia. Am. J. Obstet. Gynecol. 117: 312–315, 1973.PubMedGoogle Scholar
  307. Kitzmiller, J.L., Watt, N., and Driscoll, S.G.: Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies. Am. J. Obstet. Gynecol. 141: 773–778, 1981.PubMedGoogle Scholar
  308. Kjeldsen, J., and Pedersen, J.: Relation of residual placental blood-volume to onset of respiratory-distress syndrome in infants of diabetic and non-diabetic mothers. Lancet 1: 180184, 1967.Google Scholar
  309. Klebe, J.G., and Ingomar, C.J.: Placental transfusion in infants of diabetic mothers elucidated by placental residual blood volume. Acta Paediatr. Scand. 63: 59–64, 1974a.Google Scholar
  310. Klebe, J.G., and Ingomar, C.J.: The influence of the method of delivery and the clamping technique on the red cell volume in infants of diabetic and non-diabetic mothers. Acta Paediatr. Scand. 63: 65–69, 1974b.Google Scholar
  311. Kline, J., Stein, Z.A., Susser, M., and Warburton, D.: Smoking: a risk factor for spontaneous abortion. N. Engl. J. Med. 297: 793–796, 1977.PubMedCrossRefGoogle Scholar
  312. Klippel, J.H., Grimley, P.M., and Decker, J.L.: Lymphocyte inclusions in newborns of mothers with systemic lupus erythematosus. N. Engl. J. Med. 290: 96–97, 1974.PubMedCrossRefGoogle Scholar
  313. Klurfeld, D.M.: Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch. Pathol. 109: 445–449, 1985.Google Scholar
  314. Knörr, K., Knörr-Gärtner, H., and Uebele-Kallhardt, B.: Zur Frage der Wirkung alkylierender Substanzen auf die Entwicklung der Frucht. Geburtshilfe Frauenheilkd. 29: 601–611, 1969.PubMedGoogle Scholar
  315. Knox, G.E., Stagno, S., Volanakis, J.E., and Huddelston, J.F.: A search for antigen-antibody complexes in pre-eclampsia: further evidence against immunologic pathogenesis. Am. J. Obstet. Gynecol. 132: 87–89, 1978.PubMedGoogle Scholar
  316. König, P.A.: Über Eklampsietod undGefäß wandschaden bei Mutter und Kind. Z. Geburtshilfe Gynäkol. 146: 292–307, 1956.PubMedGoogle Scholar
  317. Koshy, M., Burd, L., Wallace, D., Moawad, A., and Baron, J.: Prophylactic red-cell transfusions in pregnant patients with sickle cell disease: a randomized cooperative study. N. Engl. J. Med. 319: 1447–1451, 1988.PubMedCrossRefGoogle Scholar
  318. Kosova, L.A., and Schwartz, S.O.: Multiple myeloma and normal pregnancy: report of a case. Blood 28: 102–111, 1966.PubMedGoogle Scholar
  319. Krayalcin, G., Imran, M., and Rosner, F.: “Blister cells”: association with pregnancy, sickle cell disease, and pulmonary infarction. J.A.M.A. 219: 1727–1729, 1972.CrossRefGoogle Scholar
  320. Kuhnert, B.R., Kuhnert, P.M., Debanne, S., and Williams, T.G.: The relationship between cadmium, zinc, and birth weight in pregnant women who smoke. Am. J. Obstet. Gynecol. 157: 1247–1251, 1987a.PubMedGoogle Scholar
  321. Kuhnert, P.M., Kuhnert, B.R., Erhard, P., Brashear, W.T., Groh-Wargo, S.L., and Webster, S.: The effect of smoking on placental and fetal zinc status. Am. J. Obstet. Gynecol. 157: 1241–1246, 1987b.PubMedGoogle Scholar
  322. Labarrere, C.A.: Placental bed biopsy technique and vascular changes. Am. J. Obstet. Gynecol. 157: 1320–1322, 1987.PubMedGoogle Scholar
  323. Lacher, M.J., and Geller, W.: Cyclophosphamide and vinblastine sulfate in Hodgkin’s disease during pregnancy. J.A.M.A. 195: 486–488, 1966.PubMedCrossRefGoogle Scholar
  324. Lau, H., Sackreuther, W., Bach, H.G., Grabberr, W., and Hundertmack, R.: Über die vorzeitige Lösung der normal sitzenden Placenta: klinische Beobachtungen an 100 Fällen. Gynaecologia 157: 143–160, 1964.PubMedGoogle Scholar
  325. Laurini, R.N., Visser, G.H.A., and Ballegoodie, E. van: Morphological fetoplacental abnormalities despite well-controlled diabetic pregnancy. Lancet 1: 800, 1984.PubMedCrossRefGoogle Scholar
  326. Lazarchick, J., and Kizer, J.: The laboratory diagnosis of lupus anticoagulants. Arch. Pathol. Lab. Med. 113: 177–180, 1989.PubMedGoogle Scholar
  327. Lederman, R.P., Lederman, E., Work, B.A., and McCann, D.S.: The relationship of maternal anxiety, plasma catecholamines, and plasma cortisol to progress in labor. Am. J. Obstet. Gynecol. 132: 495–500, 1978.PubMedGoogle Scholar
  328. Lee, R.A., Johnson, C.E., and Hanlon, D.G.: Leukemia during pregnancy. Am. J. Obstet. Gynecol. 84: 455–458, 1962.PubMedGoogle Scholar
  329. Lemtis, H.: Über die vorzeitige Lösung der normal sitzenden Plazenta. Forsch. Praxis Fortbild. 18: 231–237, 1967.Google Scholar
  330. Lemtis, H., and Hörmann, G.: Über die sogenannten Plazentametastasen maligner Blastome der Mutter. In, Fortschritte der Krebsforschung. C.G. Schmidt and O. Wetter, eds., pp. 521–527. Schattauer Verlag, Stuttgart, 1969.Google Scholar
  331. Leone, G., Monetta, E., Paparatti, G., and Boni, P.: Von Willebrand’s disease in pregnancy. N. Engl. J. Med. 293: 456, 1975.PubMedGoogle Scholar
  332. Levine, M.G., and Esser, D.: Total parenteral nutrition for the treatment of severe hyperemesis gravidarum: maternal nutritional effects and fetal outcome. Obstet. Gynecol. 72: 102–107, 1988.PubMedGoogle Scholar
  333. Li, M.C., Hertz, R., and Spencer, D.B.: Effects of methotrexate therapy upon choriocarcinomas and chorioadenomas. Proc. Soc. Exp. Biol. Med. 93: 361–366, 1956.PubMedGoogle Scholar
  334. Lichtig, C., Deutsch, M., and Brandes, J.: Vascular changes of endometrium in early pregnancy. Am. J. Clin. Pathol. 81: 702–707, 1984.PubMedGoogle Scholar
  335. Liebhardt, M.: Tkanka Laczna lozysk pochodzacych z ciaz powiklanych prdzez cukrzyce matki. Ginecol Pol. 39: 1353–1362, 1968.Google Scholar
  336. Lilford, R.J.: Classification of hypertensive disorders of pregnancy. Lancet 2: 112–113, 1989.Google Scholar
  337. Little, B.B., Snell, L.M., Klein, V.R., and Gilstrap III, L.C.: Cocaine abuse during pregnancy: maternal and fetal implications. Obstet. Gynecol. 73: 157–160, 1989.PubMedGoogle Scholar
  338. Lockshin, M.D., Druzin, M.L., and Qamar, T.: Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am. J. Obstet. Gynecol. 160: 439443, 1989.Google Scholar
  339. Lockwood, C.J., Reece, E.A., Romero, R., and Hobbins, J.C.: Anti-phospholipid antibody and pregnancy wastage. Lancet 2: 742–743, 1986.PubMedCrossRefGoogle Scholar
  340. Lockwood, C.J., Romero, R., Feinberg, R.F., Clyne, L.P., Coster, B., and Hobbins, J.C.: The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am. J. Obstet. Gynecol. 161: 369–373, 1989.PubMedGoogle Scholar
  341. Loizoll, S., Byron, M.A., Englert, H.J., David, J., Hughes, G.R.V., and Walport, M.J.: Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q. J. Med. 68: 525531, 1988.Google Scholar
  342. Long, E.G., Tsin, T.Y., Reinarz, J.A., Schnadig, V.J., McLucas, E., and Kelly, R.T.: “Hydatoxi lualba” identified. Am. J. Obstet. Gynecol. 149: 462–463, 1984.PubMedGoogle Scholar
  343. Lopez-Zeno, J.A., Carlo, W.A., O’Grady, J.P., and Fanaroff, A.A.: Infant survival following delayed postmortem cesarean delivery. Obstet. Gynecol. 76: 991–992, 1990.PubMedGoogle Scholar
  344. Lotgering, F.K., Pijpers, L., Eijck, J.v., and Wallenburg, H.C.S.: Pregnancy in a patient with diffuse cavernous hemangioma of the uterus. Am. J. Obstet. Gynecol. 160: 628–630, 1989.PubMedGoogle Scholar
  345. Lubbe, W.F., and Liggins, G.C.: Lupus anticoagulant and pregnancy. Am. J. Obstet. Gynecol. 153: 322–327, 1985.PubMedGoogle Scholar
  346. Lubbe, W.F., Butler, W.S., Palmer, S.J., and Liggins, G.C.: Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1: 1361–1363, 1963.Google Scholar
  347. Lueck, J., Brewer, J.I., Aladjem, S., and Novotny, M.: Observation of an organism found in patients with gestational trophoblastic disease and in patients with toxemia of pregnancy. Am. J. Obstet. Gynecol. 145: 15–26, 1983PubMedGoogle Scholar
  348. Lundberg, C., Marceau, F., Huey, R., and Hugli, T.E.: Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins. Immunopharmacology 12: 135–143, 1986.PubMedCrossRefGoogle Scholar
  349. Machin, G.A.: Maternal melanoma metastatic to the placenta. Pediatr. Pathol. 7: 490, 1987.Google Scholar
  350. MacLennan, A.H., Sharp, F., and Shaw-Dunn, J.: The ultra-structure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture: a comparison with ultrastructural changes in pre-eclampsia and placental insufficiency. J. Obstet. Gynaecol. Br. Commonw. 79: 113–121, 1972.CrossRefGoogle Scholar
  351. Mäkilä, U.-M., Viinikka, L., and Ylikorkala, O.: Evidence that prostacyclin deficiency is a specific feature in preeclampsia. Am. J. Obstet. Gynecol. 148: 772–774, 1984.PubMedGoogle Scholar
  352. Mäkilä, U.-M., Jouppila, P., Kirkinen, P., Viinikka, L., and Ylikorkala, O.: Placental thromboxane and prostacyclin in the regulation of placental blood flow. Obstet. Gynecol. 68: 537–540, 1986.PubMedGoogle Scholar
  353. Maqueo, M., Azuela, J.C., Karchmer, S., and Arenas, J.C.: Placental morphology in pathologic gestations with or without toxemia: observations in cases of diabetes mellitus, hydrops fetalis, twin pregnancy, placenta previa, and hydatidiform mole. Obstet. Gynecol. 26: 184–191, 1965.PubMedGoogle Scholar
  354. Marais, W.D.: Human decidual spiral arterial studies. Part II. A universal thesis on the pathogenesis of intraplacental fibrin deposits, layered thrombosis, red and white infarcts and toxic and non-toxic abruptio placentae: a microscopic study. J. Obstet. Gynaecol. Br. Commonw. 69: 213–224, 1962a.CrossRefGoogle Scholar
  355. Marais, W.D.: Human decidual spiral arterial studies. Part III. Histological patterns and some clinical implications of decidual spiral arteriosclerosis. J. Obstet. Gynaecol. Br. Commonw. 69: 225–233, 1962b.CrossRefGoogle Scholar
  356. Marais, W.D.: Human decidual spiral arterial studies. Part V. Pathogenetic patterns of intraplacental lesions. J. Obstet. Gynaecol. Br. Commonw. 69: 944–955, 1962c.CrossRefGoogle Scholar
  357. Marais, W.D.: Human decidual spiral arterial studies. Part VI: Postmortem circulation studies on an in situ placenta. S. Afr. Med. J. 36: 678–681, 1962d.PubMedGoogle Scholar
  358. Marais, W.D.: Human decidual spiral arterial studies. Part VII. The clinical evaluation of normal and abnormal spiral arterioles and of placental lesions: a statistical study. J. Obstet. Gynaecol. 70: 777–786, 1963a.CrossRefGoogle Scholar
  359. Marais, W.D.: Human decidual spiral arterial studies. Part VIII. The aetiological relationship between toxaemia-hypertension of pregnancy and spiral arterial placental pathology. S. Afr. Med. J. 37: 117–120, 1963b.PubMedGoogle Scholar
  360. Marbury, M.C., Linn, S., Monson, R., Schoenbaum, S., Stubblefield, P.G., and Ryan, K.J.: The association of alcohol consumption with outcome of pregnancy. Am. J. Public Health 73: 1165–1168, 1983.PubMedCrossRefGoogle Scholar
  361. Marcuse, P.M.: Pulmonary syncytial giant cell embolism: report of maternal death. Obstet. Gynecol. 3: 210–213, 1954.PubMedGoogle Scholar
  362. Marks, F., Ordorica, S., Hoskins, I., and Young, B.K.: Congenital hereditary fructose intolerance and pregnancy. Am. J. Obstet. Gynecol. 160: 362–363, 1989.PubMedGoogle Scholar
  363. Martinez, C.R.J.: Foetus in maternal renal failure. Lancet 1: 504, 1967.CrossRefGoogle Scholar
  364. Massobrio, M., Benedetto, C., Bertini, E., Tetta, C., and Camussi, G.: Immune complexes in preeclampsia and normal pregnancy. Am. J. Obstet. Gynecol. 152: 578–583, 1985.PubMedGoogle Scholar
  365. Mayhew, T.M., Soerensen, F.B., Klebe, J.G., and Jackson, M.R.: Growth and maturation of villi in placentae from well-controlled diabetic women. Placenta 15: 57–65, 1994.PubMedCrossRefGoogle Scholar
  366. Maymon, R., Bahari, C., and Moroz, C.: Placental isoferritin: a new serum marker in toxemia of pregnancy. Am. J. Obstet. Gynecol. 160: 681–684, 1989.PubMedGoogle Scholar
  367. McFaul, P.B., Dornan, J.C., Lamki, H., and Boyle, D.: Pregnancy complicated by maternal heart disease: a review of 519 women. Br. J. Obstet. Gynaecol. 95: 861–867, 1988.PubMedCrossRefGoogle Scholar
  368. McFayden, I.R., Price, A.B., and Geirsson, R.T.: The relation of birthweight to histological appearances in vessels of the placental bed. Br. J. Obstet. Gynaecol. 93: 476–481, 1986.Google Scholar
  369. McGlothlin, W.H., Sparkes, R.S., and Arnold, D.O.: Effect of LSD on human pregnancy. J.A.M.A. 212: 1483–1487, 1970.PubMedCrossRefGoogle Scholar
  370. McGowan, L.: Cancer and pregnancy. Obstet. Gynecol. Surv. 19: 285–307, 1964.CrossRefGoogle Scholar
  371. McKay, D.G., Jewett, J.F., and Reid, D.E.: Endotoxin shock and the generalized Shwartzman reaction in pregnancy. Am. J. Obstet. Gynecol. 78: 546–566, 1959.Google Scholar
  372. McLaughlin, P.J., Stirrat, G.M., Redman, C.W.G., and Levinsky, R.J.: Immune complexes in normal and preeclamptic pregnancy. Lancet 1: 934–935, 1979.PubMedCrossRefGoogle Scholar
  373. McVerry, B.A., Machin, S.J., Parry, H., and Goldstone, A.H.: Reduced prostacyclin activity in systemic lupus erythematosus. Ann. Rheum. Dis. 39: 524–525, 1980.PubMedCrossRefGoogle Scholar
  374. Menon, R.K., Cohen, R.M., Sperling, M.A., Cutfield, W.S., Mimouni, F., and Khoury, J.C.: Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N. Engl. J. Med. 323: 309–315, 1990.PubMedCrossRefGoogle Scholar
  375. Mercado, A., Johnson, G., Calver, D., and Sokol, R.J.: Cocaine, pregnancy, and postpartum intracerebral hemorrhage. Obstet. Gynecol. 73: 467–468, 1989.PubMedGoogle Scholar
  376. Mercer, B., Drouin, J., Jolly, E., and d’Anjou, G.: Primary thrombocythemia in pregnancy: a report of two cases. Am. J. Obstet. Gynecol. 159: 127–128, 1988.PubMedGoogle Scholar
  377. Messer, R.H.: Symposium on bleeding disorders in pregnancy: observations in pregnancy. Am. J. Obstet. Gynecol. 156: 1419–1425, 1987.PubMedGoogle Scholar
  378. Metcalfe, J., Novy, M.J., and Peterson, E.N.: Reproduction at high altitude. In, Comparative Aspects of Reproductive Failure. K. Benirschke, ed., pp. 447–457. Springer-Verlag, New York, 1966.Google Scholar
  379. Meyer, M.B., and Tonascia, J.A.: Maternal smoking, pregnancy complications, and perinatal mortality. Am. J. Obstet. Gynecol. 128: 494–502, 1977.PubMedGoogle Scholar
  380. Mijer, F., and Olsen, R.N.: Transplacental passage of L. E. factor. J. Pediatr. 52: 690–693, 1958.CrossRefGoogle Scholar
  381. Mills, J.L., Simpson, J.L., Driscoll, S.G., Jovanovic-Peterson, L., Allen, M.V., Aarons, J.H., Metzger, B., Bieber, F.R., Knopp, R.H., Holmes, L.B., Peterson, C.M., WithiamWilson, M., Brown, Z., Ober, C., Harley, E., MacPherson, T.A., Duckles, A., Mueller-Heubach, E., NICHD, and HD-DEPS: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N. Engl. J. Med. 319: 1617–1623, 1988.PubMedCrossRefGoogle Scholar
  382. Milo, R., Neuman, M., Klein, C., Caspi, E., and Arlazoroff, A.: Acute intermittent porphyria in pregnancy. Obstet. Gynecol. 73: 450–452, 1989.PubMedGoogle Scholar
  383. Miodovnik, M., Skillman, C., Holroyde, J.C., Butler, J.B., Wen’del, J.S., and Siddiqi, T.A.: Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am. J. Obstet. Gynecol. 153: 439–442, 1985.PubMedGoogle Scholar
  384. Mirro, R., and Brown, D.R.: Edema, proteinuria, thrombocytopenia, and leukopenia in infants of preeclamptic mothers. Am. J. Obstet. Gynecol. 144: 851–852, 1982.PubMedGoogle Scholar
  385. Moore, T.R., Sorg, J., Miller, L., Key, T.C., and Resnik, R.: Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am. J. Obstet. Gynecol. 155: 883–888, 1986.PubMedGoogle Scholar
  386. Morales, W.J., and Stroup, M.: Intracranial hemorrhage in utero due to isoimmune neonatal thrombocytopenia. Obstet. Gynecol. 65: 205–24S, 1985.Google Scholar
  387. Mordel, N., Birkenfeld, A., Goldfarb, A.N., and Rachmilewitz, E.A.: Successful full-term pregnancy in homozygous ß-thalassemia major: case report and review of the literature. Obstet. Gynecol. 73: 837–840, 1989.PubMedGoogle Scholar
  388. Morrow, R.J., Ritchie, J.W.K., and Bull, S.B.: Maternal cigarette smoking: the effects on umbilical and uterine blood flow velocity. Am. J. Obstet. Gynecol. 159: 1069–1071, 1988.PubMedGoogle Scholar
  389. Mueller-Eckhardt, C., Kiefel, V., Jovanovic, V., Künzel, W., Becker, T., Wolf, H., and Zeh, K.: Prenatal treatment of alloimmune thrombocytopenia. Lancet 2: 910, 1988.Google Scholar
  390. Muller, G., Philippe, E., Lefakis, P., de Mot-Leclair, M., Dreyfus, J., Nusynowicz, G., Renaud, R., and Gandar, R.: Les lésions placentaires de la gestose: étude anatomoclinique. Gynecol. Obstet. (Paris) 70: 309–316, 1971.Google Scholar
  391. Mund, A., Simson, J., and Rothfield, N.: Effect of pregnancy on course of systemic lupus erythematosus. J.A.M.A. 183: 917–920, 1963.PubMedCrossRefGoogle Scholar
  392. Murphy, J.F., Mulcahy, R., and Drumm, J.E.: Smoking and the fetus. Lancet 2: 36, 1977.CrossRefGoogle Scholar
  393. Musci, T.J., Roberts, J.M., Rodgers, G.M., and Taylor, R.N.: Mitogenic activity is increased in the sera of preeclamptic women before birth. Am. J. Obstet. Gynecol. 159: 1446–1451, 1988.PubMedGoogle Scholar
  394. Myers, R.E., and Fujikura, T.: Placental changes after experimental abruptio placentae and fetal vessel ligation of rhesus monkey placenta. Am. J. Obstet. Gynecol. 100: 846–851, 1968.Google Scholar
  395. Nadji, P., and Sommers, S.C.: Lesions of toxemia in first trimester pregnancies. Am. J. Clin. Pathol. 59: 344–349, 1973.PubMedGoogle Scholar
  396. Naeye, R.L.: Placental infarction leading to fetal or neonatal death. A prospective study. Obstetr. Gynecol. 50: 583–588, 1977.Google Scholar
  397. Naeye, R.L.: Relationship of cigarette smoking to congenital anomalies and perinatal death: a prospective study. Am. J. Pathol. 90: 289–294, 1978.PubMedGoogle Scholar
  398. Naeye, R.L., Blanc, W., Leblanc, W., and Khatamee, M.A.: Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. J. Pediatr. 83: 1055–1061, 1973.PubMedCrossRefGoogle Scholar
  399. Naeye, R.L., Harkness, W.L., and Utts, J.: Abruptio placentae and perinatal death: a prospective study. Am. J. Obstet. Gynecol. 128: 740–746, 1977.PubMedGoogle Scholar
  400. Nagey, D.A., Fortier, K.J., and Linder, J.: Pregnancy complicated by periarteritis nodosa: induced abortion as an alternative. Am. J. Obstet. Gynecol. 147: 103–105, 1983.PubMedGoogle Scholar
  401. Ness, P.M., Budzynski, A.Z., Olexa, S.A., and Rodvien, R.: Congenital hypofibrinogenemia and recurrent placental abruption. Obstet. Gynecol. 61: 519–523, 1983.PubMedGoogle Scholar
  402. Nicholson, H.O.: Cytotoxic drugs in pregnancy. J. Obstet. Gynaecol. Br. Commonw. 75: 307–312, 1968.PubMedCrossRefGoogle Scholar
  403. Nielsen, F.H., Jacobsen, B.B., and Rolschau, J.: Pregnancy complicated by extreme hyperlipaemia and foam-cell accumulation in placenta. Acta Obstet. Gynecol. Scand. 52: 83–89, 1973.CrossRefGoogle Scholar
  404. Nilsson, I.M., Astedt, B., Hedner, U., and Berezin, D.: Intrauterine death and circulating anticoagulant, “antithromboplastin.” Acta Med. Scand. 197: 153–159, 1975.Google Scholar
  405. Niswander, R.K., and Gordon, M.: The Women and their Pregnancies. p. 43. Saunders, Philadelphia, 1972.Google Scholar
  406. Nordlund, J.J., DeVita, V.T., and Carbone, P.P.: Severe vinblastine-induced leukopenia during late pregnancy with delivery of normal infant. Ann. Intern. Med. 69: 581–582, 1968.PubMedCrossRefGoogle Scholar
  407. Notelvitz, M., Bottoms, S.F., Dase, D.F., and Leichter, P.J.: Painless abruptio placentae. Obstet. Gynecol. 53: 270–272, 1979.Google Scholar
  408. Nummi, S., Koivisto, M., and Hakosalo, J.: Acute leukaemia in pregnancy with placental involvement. Ann. Chir. Gynaecol. Fenn. 62: 394–398, 1973.PubMedGoogle Scholar
  409. Nunez, J.A.C.: La placenta de las cardiacas. Rev. Esp. Obstet. Ginecol. 22: 129–134, 1963.Google Scholar
  410. O’Brien, W.F., Knuppel, R.A., Saba, H.I., Angel, J.L., Benoit, R., and Bruce, A.: Platelet inhibitory activity in placentas from normal and abnormal pregnancies. Obstet. Gynecol. 70: 597–600, 1987.PubMedGoogle Scholar
  411. O’Brien, W.F., Knuppel, R.A., Saba, H.I., Angel, J.L., Benoit, R., and Bruce, A.: Serum prostacyclin binding and half-life in normal and hypertensive pregnant women. Obstet. Gynecol. 73: 43–46, 1988.Google Scholar
  412. Oga, M., Matsui, N., Anai, T., Yoshimatsu, J., Inoue, I., and Miyakawa, I.: Copper disposition of the fetus and placenta in a patient with untreated Wilson’s disease. Am. J. Obstet. Gynecol. 169: 196–198, 1993.PubMedGoogle Scholar
  413. Ohba, T., Matsuo, I., Katabuchi, H., Nishimura, H., Fujisaki, S., and Okamura, H.: Adult T-cell leukemia/lymphoma in pregnancy. Obstet. Gynecol. 72: 445–447, 1988.PubMedGoogle Scholar
  414. Okudaira, Y., Hirota, K., Cohen, S., and Strauss, L.: Ultra-structure of the human placenta in maternal diabetes mellitus. Lab. Invest. 15: 910–926, 1966.PubMedGoogle Scholar
  415. O’Leary, J.A.: A continuing study of sarcoidosis and pregnancy. Am. J. Obstet. Gynecol. 101: 610–613, 1968.Google Scholar
  416. Ong, P.J.L., and Burton, G.J.: Thinning of the placental villous membrane during maintenance in hypoxic organ culture: structural adaptation or syncytial degeneration ? Eur. J. Obstet. Gynecol. Reprod. Biol. 39: 103–110, 1991.PubMedCrossRefGoogle Scholar
  417. Orr, J.W., Grizzle, W.E., and Huddleston, J.F.: Squamous cell carcinoma metastatic to placenta and ovary. Obstet. Gynecol. 59: 81S - 83S, 1982.PubMedGoogle Scholar
  418. Out, H.J., Bruinse, H.W., Christiaens, G.C.M.L., Vliet, M.v., de Groot, P.G., Nieuwenhuis, H.K., and Derksen, R.H.W.M.: A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am. J. Obstet. Gynecol. 167: 26–32, 1992.PubMedGoogle Scholar
  419. Owen, J., and Hauth, J.C.: Polyarteritis nodosa in pregnancy: a case report and brief literature review. Am. J. Obstet. Gynecol. 160: 606–607, 1989.PubMedGoogle Scholar
  420. Padmanabhan, R., Al-Zuhair, A.G.H., and Ali, A.H.: Histopathological changes of the placenta in diabetes induced by maternal administration of streptozotocin during pregnancy in the rat. Congen. Anom. (Jpn.) 28: 1–15, 1988.CrossRefGoogle Scholar
  421. Page, D.V., Brady, K., Mitchell, J., Pehrson, J., and Wade, G.: The pathology of intrauterine thyrotoxicosis: two case reports. Obstet. Gynecol. 72: 479–481, 1988.PubMedGoogle Scholar
  422. Page, D.V., Brady, K., and Ward, S.: The placental pathology of substance abuse [abstract 410]. Mod. Pathol. 2 (1): 69A, 1989.Google Scholar
  423. Palmer, A.E., London, W.T., Sly, D.L., and Rice, J.M.: Toxemia of pregnancy (preeclampsia, eclampsia, hypertensive disorders of pregnancy). In, Spontaneous Animal Models of Human Disease. Vol. I. E.J. Andrews, B.C. Ward, and N.H. Altman, eds., pp. 213–215. Academic Press, Orlando, FL, 1979.Google Scholar
  424. Parker, C.R., Illingworth, D.R., Bissonette, J., and Carr, B.R.: Endocrine changes during pregnancy in a patient with homozygous familial hypobetalipoproteinemia. N. Engl. J. Med. 314: 557–560, 1986.PubMedCrossRefGoogle Scholar
  425. Pavelka, M., Pavelka, R., and Gerstner, G.: Ultrastructure of the syncytiotrophoblast of the human term placenta in EPH-gestosis. Gynecol. Obstet. Invest. 10: 177–185, 1979.PubMedCrossRefGoogle Scholar
  426. Payne, R.: Neonatal neutropenia and leukoagglutinins. Pediatrics 33: 194–204, 1964.PubMedGoogle Scholar
  427. Peaceman, A.M., and Rehnberg, K.A.: The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 169: 1403–1406, 1993.PubMedGoogle Scholar
  428. Peaceman, A.M., Silver, R.K., MacGregor, S.N., and Socol, M.L.: Interlaboratory variation in antiphospholipid antibody testing. Am. J. Obstet. Gynecol. 166: 1780–1787, 1992.PubMedGoogle Scholar
  429. Pearce, J.M., and McParland, P.: Doppler uteroplacental waveforms. Lancet 1: 1287–1288, 1988.CrossRefGoogle Scholar
  430. Penn, I., Makowski, E.L., and Harris, P.: Parenthood following renal and hepatic transplantation. Transplantation 30: 397–400, 1980.PubMedCrossRefGoogle Scholar
  431. Pestelek, B., and Kapor, M.: Pheochromocytoma and abruptio placentae. Am. J. Obstet. Gynecol. 85: 538–540, 1963.PubMedGoogle Scholar
  432. Pijnenborg, R., Anthony, J., Davari, D.A., Rees, A., Tiltman, A., Vercruysse, L., and van Assche, A.: Placental bed spiral arteries in hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98: 648–655, 1991.PubMedCrossRefGoogle Scholar
  433. Pinette, M.G., Loftus-Brault, K., Nardi, D.A., and Rodis, J.F.: Maternal smoking and accelerated placental maturation. Obstet. Gynecol. 73: 379–382, 1989.PubMedGoogle Scholar
  434. Pitkin, R.M., Plank, C.J., and Filer, L.J.: Fetal and placental composition in experimental maternal diabetes. Proc. Soc. Exp. Biol. Med. 138: 163–166, 1971.PubMedGoogle Scholar
  435. Pittard III, W.B., Schleich, D.M., Geddes, K.M., and Sorensen, R.U.: Newborn lymphocyte subpopulations: the influence of labor. Am. J. Obstet. Gynecol. 160: 151–154, 1989.PubMedGoogle Scholar
  436. Platt, H.S.: Effect of maternal sickle cell trait on perinatal mortality. B.M.J. 2: 334–338, 1971.CrossRefGoogle Scholar
  437. Pober, J.S.: Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am. J. Pathol. 133: 426–433, 1988.PubMedGoogle Scholar
  438. Pollack, R.N., Pollack, M., and Rochon, L.: Pregnancy complicated by medulloblastoma with metastases to the placenta. Obstet. Gynecol. 81: 858–859, 1993.PubMedGoogle Scholar
  439. Polzin, W.J., Kopelman, J.N., Robinson, R.D., Read, J.A., and Brady, K.: The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet. Gynecol. 78: 1108–1111, 1991.PubMedGoogle Scholar
  440. Potau, N., Riudor, E., and Ballabriga, A.: Insulin receptors in human placenta in relation to fetal weight and gestational age. Pediatr. Res. 15: 798–802, 1981.PubMedGoogle Scholar
  441. Potter, J.F., and Schoeneman, M.: Metastasis of maternal cancer to the placenta and fetus. Cancer 25: 380–388, 1970.PubMedCrossRefGoogle Scholar
  442. Prentice, R.L., Gatenby, P.A., Loblay, R.H., Shearman, R.P., Kronenberg, H., and Basten, A.: Lupus anticoagulant in pregnancy. Lancet 2: 464, 1984.PubMedCrossRefGoogle Scholar
  443. Priesel, A., and Winkelbauer, A.: Placentare Übertragung des Lymphogranuloms. Virchows Arch. [Pathol. Anat.] 262: 749–765, 1926.Google Scholar
  444. Pritchard, J.A., Scott, D.E., Whalley, P.J., and Haling, R.F.: Infants of mothers with megaloblastic anemia due to folate deficiency. J.A.M.A. 211: 1982–1984, 1970.PubMedCrossRefGoogle Scholar
  445. Pritchard, M.H., Jessop, J.D., Trenchard, P.M., and Whiltaker, J.A.: Systemic lupus erythematosus, repeated abortions, and thrombocytopenia. Ann. Rheum. Dis. 37: 476–478, 1978.PubMedCrossRefGoogle Scholar
  446. Provost, T.T., Watson, R., Gammon, W.R., Radowsky, M., Harley, J.B., and Reichlin, M.: The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies. N. Engl. J. Med. 316: 1135–1138, 1987.PubMedCrossRefGoogle Scholar
  447. Pulitzer, D.R., Collins, P.C., and Gold, R.G.: Embryonic implantation in carcinoma of the endometrium. Arch. Pathol. Lab. Med. 109: 1089–1092, 1985.PubMedGoogle Scholar
  448. Ramahi, A.J., Lewkow, L.M., Dombrowski, M.P., and Bottoms, S.F.: Sickle cell E hemoglobinopathy and pregnancy. Obstet. Gynecol. 71: 493–495, 1988.Google Scholar
  449. Rauramo, I., and Forss, M.: Effect of exercise on placental blood flow in pregnancies complicated by hypertension, diabetes or intrahepatic cholestasis. Acta Obstet. Gynecol. Scand. 67: 15–20, 1988.CrossRefGoogle Scholar
  450. Raymond, E.G., and Mills, J.L.: Placental abruption: maternal risk factors and associated fetal conditions. Acta Obstet. Gynecol. Scand. 72: 633–639, 1993.CrossRefGoogle Scholar
  451. Read, E.J., and Platzer, P.B.: Placental metastasis from maternal carcinoma of the lung. Obstet. Gynecol. 58: 387–391, 1981.PubMedGoogle Scholar
  452. Redman, C.W.G., and Jefferies, M.: Revised definition of pre-eclampsia. Lancet 1: 809–812, 1988.PubMedCrossRefGoogle Scholar
  453. Redman, C.W.G., Bodmer, J.G., Bodmer, W.F., Beilin, L.J., and Bonnar, J.: HLA antigens in severe pre-eclampsia. Lancet 2: 397–399, 1978.PubMedCrossRefGoogle Scholar
  454. Reece, E.A., Romero, R., Clyne, L.P., Kriz, N.S., and Hobbins, J.C.: Lupus-like anticoagulant in pregnancy. Lancet 1: 344–345, 1984.PubMedCrossRefGoogle Scholar
  455. Reece, E.A., Gabrielli, S., Cullen, M.T., Zheng, X.-Z., Hobbins, J.C., and Harris, E.N: Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am. J. Obstet. Gynecol. 163: 162–169, 1990.PubMedGoogle Scholar
  456. Reiss, R.E., Kuwabara, T., Smith, M.L., and Gahl, W.A.: Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis. N. Engl. J. Med. 319: 223–226, 1988.PubMedCrossRefGoogle Scholar
  457. Reshetnikova, O.S., Burton, G.J., and Milovanov, A.P.: Hypoxia at altitude and villous vascularisation in the mature human placenta [abstract A]. Placenta 14: 62, 1993.CrossRefGoogle Scholar
  458. Retik, A.B., Sabesin, S.M., Hume, R., Malmgren, R.A., and Ketcham, A.S.: The experimental transmission of malignant melanoma cells through the placenta. Surg. Gynecol. Obstet. 114: 485–489, 1962.PubMedGoogle Scholar
  459. Rewell, R.E., and Whitehouse, W.L.: Malignant metastasis to the placenta from carcinoma of the breast. J. Pathol. Bacteriol. 91: 255–256, 1966.PubMedCrossRefGoogle Scholar
  460. Reynolds, A.G.: Placental metastasis from malignant melanoma: report of a case. Obstet. Gynecol. 6: 205–209, 1955.PubMedGoogle Scholar
  461. Rice, J.P., Kay, H.H., and Mahony, B.S.: The clinical significance of uterine leiomyomas in pregnancy. Am. J. Obstet. Gynecol. 160: 1212–1216, 1989.PubMedGoogle Scholar
  462. Richards, D.S., Wagman, A.J., and Cabaniss, M.L.: Ascites not due to congestive heart failure in a fetus with lupus-induced heart block. Obstet. Gynecol. 76: 957–959, 1990.PubMedGoogle Scholar
  463. Rigby, P.G., Hanson, T.A., and Smith, R.S.: Passage of leukemic cells across the placenta. N. Engl. J. Med. 271: 124–127, 1964.PubMedCrossRefGoogle Scholar
  464. Robb, S.A., and Hytten, F.E.: Placental glycogen. Br. J. Obstet. Gynaecol. 83: 43–53, 1976.PubMedCrossRefGoogle Scholar
  465. Robbins, P.G., Gorbach, A.G., and Reid, D.E.: Neurologic abnormalities at one year in infants delivered after late-pregnancy hemorrhage. Obstet. Gynecol. 29: 358–361, 1967.PubMedGoogle Scholar
  466. Roberts, J.M.: Classification of hypertensive disorders of pregnancy. Lancet 2: 112, 1989.Google Scholar
  467. Robertson, W.B., Brosens, I., and Dixon, H.G.: The pathological response of the vessels of the placental bed to hypertensive pregnancy. J. Pathol. Bacteriol. 93: 581–592, 1967.PubMedCrossRefGoogle Scholar
  468. Robertson, W.B., Khong, T.Y., Brosens, I., DeWolff, F., Sheppard, B.L., and Bonnar, J.: The placental bed biopsy: review from three European centers. Am. J. Obstet. Gynecol. 155: 401–412, 1986.PubMedGoogle Scholar
  469. Robinson, M.: Salt in pregnancy. Lancet 1: 178–181, 1958.PubMedCrossRefGoogle Scholar
  470. Rodriguez, S.U., Leikin, S.L., and Hiller, M.C.: Neonatal thrombocytopenia associated with ante-partum administration of thiazide drugs. N. Engl. J. Med. 270: 881–884, 1964.PubMedCrossRefGoogle Scholar
  471. Roe, D.A., Little, B.B., Bawdon, R.E., and Gilstrap, L.C.: Metabolism of cocaine by human placentas: implications for fetal exposure. Am. J. Obstet. Gynecol. 163: 715–718, 1990.PubMedGoogle Scholar
  472. Roffman, B.Y., and Simons, M.: Syncytial trophoblastic embolism associated with placenta increta and preeclampsia. Am. J. Obstet. Gynecol. 104: 1218–1220, 1969.PubMedGoogle Scholar
  473. Rosenberg, A.M., Bingham, M.C., and Fong, K.C.: Antinuclear antibodies during pregnancy. Obstet. Gynecol. 68: 560–562, 1986.PubMedGoogle Scholar
  474. Rosenfeld, C.R.: Preeclampsia: a review of the role of Prostaglandins. Obstet. Gynecol. 72: 284–285, 1988.PubMedGoogle Scholar
  475. Rosenow, E.C., and Lee, R.A.: Cystic fibrosis and pregnancy. J. A. M. A. 203: 227–230, 1968.PubMedCrossRefGoogle Scholar
  476. Rosner, F., Soong, B.C., Krim, M., and Miller, S.P.: Normal pregnancy in a patient with multiple myeloma. Obstet. Gynecol. 31: 811–820, 1968.PubMedGoogle Scholar
  477. Rosove, M.H., Tabsh, K., Wasserstrum, N., Howard, P., Hahn, B.H., and Kalunian, K.C.: Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin andtibodies. Obstet. Gynecol. 75: 630–634, 1990.PubMedGoogle Scholar
  478. Rote, N.S., and Caudle, M.R.: Circulating immune complexes in pregnancy, preeclampsia, and autoimmune diseases: evaluation of Raji cell enzyme-linked immunosorbent assay and polyethylene glycol precipitation methods. Am. J. Obstet. Gynecol. 147: 267–273, 1983.PubMedGoogle Scholar
  479. Rothman, L.A., Cohen, C.J., and Astarloa, J.: Placental and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature. Am. J. Obstet. Gynecol. 116: 1023–1034, 1973.PubMedGoogle Scholar
  480. Rouget, J.P., Goudemand, J., Montreuil, G., Cosson, A., and Jaillard, J.: Lupus anticoagulant: a familial observation. Lancet 2: 105, 1982.PubMedCrossRefGoogle Scholar
  481. Rubin, D.H., Krasilikoff, P.A., Leventhal, J.M., Weile, B., and Berget, A.: Effect of passive smoking on birthweight. Lancet 2: 415–417, 1986.PubMedCrossRefGoogle Scholar
  482. Rushton, D.I.: Trophoblast cells in peripheral blood. Lancet 2: 1153–1154, 1984.PubMedCrossRefGoogle Scholar
  483. Salafia, C.M., and Silberman, L.: Placental pathology and abnormal fetal heart rate patterns in gestational diabetes. Pediatr. Pathol. 9: 513–520, 1989.PubMedCrossRefGoogle Scholar
  484. Samaan, N.A., Gallager, H.S., McRoberts, W.A., and Holt, B.: Differential evaluation of the fetoplacental unit in patients with diabetes. Am. J. Obstet. Gynecol. 120: 825–832, 1974.PubMedGoogle Scholar
  485. Sanerkin, N.G., and Evans, D.M.D.: Bilateral renal cortical necrosis in infants, associated with maternal antepartum haemorrhage. J. Pathol. Bacteriol. 90: 269–274, 1965.PubMedCrossRefGoogle Scholar
  486. Sanyal, M.K., Li, Y.-L., Biggers, W., Satish, J., and Barnea, E.R.: Augmentation of polynuclear aromatic hydrocarbon metabolism of human placental tissues of first-trimester pregnancy by cigarette smoke exposure. Am. J. Obstet. Gynecol. 168: 1587–1597, 1993.PubMedGoogle Scholar
  487. Sasseville, D., Wilkinson, R.D., and Schnader, J.Y.: Dermatoses of pregnancy. Int. J. Dermatol. 20: 223–241, 1981.PubMedCrossRefGoogle Scholar
  488. Schaffner, T., Taylor, K., Bartucci, E.J., Fischer-Dzoga, K., Beeson, J.H., Glasgo, S., and Wissler, R.W.: Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100: 57–80, 1980.PubMedGoogle Scholar
  489. Schenker, J.G., and Polishuk, W.Z.: Idiopathic thrombo- cytopenia in pregnancy. Gynaecologia 165: 271–283, 1968.PubMedGoogle Scholar
  490. Schenker, J.G., Segal, S., and Polishuk, W.Z.: Systemic lupus erythematosus in pregnancy. Harefuah 82: 1–4, 1972.Google Scholar
  491. Schiff, E., Peleg, E., Goldenberg, M., Rosenthal, T., Ruppin, E., Tamarkin, M., Barkal, G., Ben-Baruch, G., Yahal, I., Blankstein, J., Goldman, B., and Mashiach, S.: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N. Engl. J. Med. 321: 351–356, 1989.PubMedCrossRefGoogle Scholar
  492. Schmidt, B.K., Muraji, T., and Zipursky, A.: Low anti-thrombin III in neonatal shock: DIC or non-specific protein depletion ? Eur. J. Pediatr. 145: 500–503, 1986.PubMedCrossRefGoogle Scholar
  493. Schmorl, G.: Pathologisch-Anatomische Untersuchungen Über Puerperale Eklampsie. Vogel, Leipzig, 1893.Google Scholar
  494. Schneider, C.L.: “Fibrin embolism” (disseminated intra-vascular coagulation) with defibrination as one of the end results during placenta abruptio. Surg. Gynecol. Obstet. 92: 27–34, 1951.PubMedGoogle Scholar
  495. Schneider, C.L.: Abruptio placentae after fetal death in utero. Obstet. Gynecol. 1: 321–326, 1953.PubMedGoogle Scholar
  496. Schuhmann, R., and Geier, G.: Histomorphologische Placentabefunde bei EPH-Gestose: ein Beitrag zur Morphologie der insuffizienten Placenta. Arch. Gynecol. 213: 31–47, 1972.Google Scholar
  497. Schuhmann, R., and Lehmann, W.D.: Beziehungen zwischen Placentamorphologie and biochemischen Befunden bei EPH-Gestose and Diabetes mellitus: dehydroandrosteronbelastungstest, in vitro Umwandlungsrate von 4–14C-Dehydroepiandrosteron in Oestrogene, Oestrogenausscheidung im 24 Std-Urin. Arch. Gynecol. 215:72–84, 1973.Google Scholar
  498. Scott, J.R., and Beer, A.A.: Immunologic aspects of pre- eclampsia. Am. J. Obstet. Gynecol. 125: 418–427, 1976.PubMedGoogle Scholar
  499. Scott, J.R., Branch, D.W., Kochenour, N.K., and Ward, K.: Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am. J. Obstet. Gynecol. 159: 1055–1056, 1988.PubMedGoogle Scholar
  500. Scott, J.S.: Immunological diseases and pregnancy. B.M.J. 1: 1559–1568, 1966.CrossRefGoogle Scholar
  501. Scott, J.S., and Jenkins, D.M.: Review article: immunogenetic factors in aetiology of pre-eclampsia/eclampsia (gestosis). J. Med. Genet. 13: 200–207, 1976.PubMedCrossRefGoogle Scholar
  502. Scott, J.S., Jenkins, D.M., and Need, J.A.: Immunology of pre-eclampsia. Lancet 1: 704–706, 1978.PubMedCrossRefGoogle Scholar
  503. Scully, R.E., Galdabini, J.J., and McNeely, B.U.: Cabot Case # 37–1976. N. Engl. J. Med. 295: 608–614, 1976.CrossRefGoogle Scholar
  504. Seip, M.: Systemic lupus erythematosus in pregnancy with haemolytic anaemia, leucopenia and thrombocytopenia in the mother and her newborn infant. Arch. Dis. Child. 35: 364–366, 1960.PubMedCrossRefGoogle Scholar
  505. Shanklin, D.R.: The human placenta with especial reference to infarction and toxemia. Obstet. Gynecol. 13: 325–336, 1959.PubMedGoogle Scholar
  506. Shanklin, D.R.: Clinicopathologic correlates in placentas from women with sickle cell disease [abstract PPC-15]. Am. J. Pathol. 82: 5A, 1976.Google Scholar
  507. Shanklin, D.R., and Sibai, B.M.: Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am. J. Obstet. Gynecol. 161: 735–741, 1989.Google Scholar
  508. Sharon, R., and Amar, A.: Maternal anti-HLA antibodies and neonatal thrombocytopenia. Lancet 1: 1313, 1981.PubMedCrossRefGoogle Scholar
  509. Shaw, E.B., and Rees, E.L.: Fetal damage due to aminopterin ingestion: follow-up at 171 years of age. Am. J. Dis. Child. 134: 1172, 1980.PubMedGoogle Scholar
  510. Sheridan-Pereira, M., Porreco, R., Hays, T., and Burke, M.S.: Neonatal aortic thrombosis associated with the lupus anticoagulant. Obstet. Gynecol. 71: 1016–1018, 1988.PubMedGoogle Scholar
  511. Sholl, J.S.: Abruptio placentae: clinical management in nonacute cases. Am. J. Obstet. Gynecol. 156: 40–51, 1987.PubMedGoogle Scholar
  512. Siegel, P.: Beziehungen zwischen eklamptischen Placentarveränderungen und intrauterinem Fruchttod. Fortschr. Med. 80: 75–82, 1962.Google Scholar
  513. Silver, M.M.: Massive placental infarction due to the lupus anticoagulant [abstract 508]. Mod. Pathol. 1: 85A, 1988.Google Scholar
  514. Silver, M.M., Laxer, R.M., Laskin, C.A., Smallhorn, J.F., and Gare, D.J.: Association of fetal heart block and massive placental infarction due to maternal autoantibodies. Pediatr. Pathol. 12: 131–139, 1992a.PubMedCrossRefGoogle Scholar
  515. Silver, R.K., MacGregor, S.N., Pasternak, J.F., and Neely, S.E.: Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet. Gynecol. 80: 497–499, 1992b.PubMedGoogle Scholar
  516. Silverstein, M.N., Aaro, L.A., and Kempers, R.D.: Evans’ syndrome and pregnancy. Am. J. Med. Sci. 252: 206–211, 1966.PubMedCrossRefGoogle Scholar
  517. Slate, W.G., and Graham, A.R.: Scleroderma and pregnancy. Am. J. Obstet. Gynecol. 101: 335–341, 1968.PubMedGoogle Scholar
  518. Sletnes, K.E., Wisloff, F., Moe, N., and Dale, P.O.: Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet. Gynecol. Scand. 71: 112–117, 1992.CrossRefGoogle Scholar
  519. Smith, M.L., Clark, K.F., Davis, S.E., Greene, A.A., Marcusson, E.G., Chen, Y.-J., and Schneider, J.A.: Diagnosis of cystinosis with use of placenta. N. Engl. J. Med. 321: 397, 1989.PubMedCrossRefGoogle Scholar
  520. Smythe, A.R., Underwood, P.B., and Kreutner, A.: Metastatic placental tumors: report of three cases. Am. J. Obstet. Gynecol. 125: 1149–1151, 1976.PubMedGoogle Scholar
  521. Sokol, R.J., Hutchison, P., Cowan, D., and Reed, G.B.: Amelanotic melanoma metastatic to the placenta. Am. J. Obstet. Gynecol. 124: 431–432, 1976.PubMedGoogle Scholar
  522. Sokol, R.J., Miller, S.I., and Reed, G.: Alcohol abuse during pregnancy: an epidemiologic study: alcoholism. Clin. Exp. Res. 4: 135–145, 1980.CrossRefGoogle Scholar
  523. Soma, H., Yoshida, K., Mukaida, T., and Tabuchi, Y.: Morphologic changes in the hypertensive placenta. Contrib. Gynecol. Obstet. 9: 58–75, 1982.PubMedGoogle Scholar
  524. Sophian, J.: Antibodies to trophoblast post partum and toxemia. Am. J. Obstet. Gynecol. 88: 280–281, 1964.Google Scholar
  525. Sorensen, P.G., Mickley, H., Diederichsen, H., and Grunnert, N.: Maternal antibodies and neonatal thrombocytopenia. Lancet 1: 452, 1982.PubMedCrossRefGoogle Scholar
  526. Soyannwo, M.A.O., Armstrong, M.J., and McGeown, M.G.: Survival of the foetus in a patient in acute renal failure. Lancet 2: 1009–1011, 1966.PubMedCrossRefGoogle Scholar
  527. Spellacy, W.N.: Scleroderma and pregnancy: report of a case. Obstet. Gynecol. 23: 297–300, 1964.PubMedGoogle Scholar
  528. Sridama, V., Yang, S.L., Moawad, A., and De Groot, L.J.: T-cell subsets in patients with preeclampsia. Am. J. Obstet. Gynecol. 147: 566–569, 1983.PubMedGoogle Scholar
  529. Stark, J., and Kaufmann, P.: Infarktgenese in der Placenta. Arch. Gynecol. 217: 189–208, 1974.Google Scholar
  530. Steigrad, K.: Über die Beziehung von Plazentarinfarkten zur Schwangerschafts-Nephropathie: Zugleich ein Beitrag zur Pathologie der Plazenta. Gynaecologia 134: 273–322, 1952.PubMedGoogle Scholar
  531. Steinke, J., and Driscoll, S.G.: The extractable insulin content of pancreas from fetuses and infants of diabetic and control mothers. Diabetes 14: 573–578, 1965.PubMedGoogle Scholar
  532. Stephenson, H.E., Terry, C.W., Lukens, J.N., Shively, J.A., Busby, W.E., Stoeckle, H.E., and Esterly, J A: Immunologic factors in human melanoma “metastatic” to products of gestation (with exchange transfusion to mother). Surgery 69: 515–522, 1971.PubMedGoogle Scholar
  533. Stormorken, H., Gjemdal, T., and Njoro, K.: Lupus anticoagulant: A unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency. Gynecol. Obstet. Invest. 26: 83–88, 1988.PubMedCrossRefGoogle Scholar
  534. Streiff, R.R., and Little, A.B.: Folic acid deficiency in pregnancy. N. Engl. J. Med. 276: 776–779, 1967.PubMedCrossRefGoogle Scholar
  535. Stuart, M.J., Clark, D.A., Sunderji, S.G., Allen, J.B., Yambo, T., Elrad, H., and Slott, J.H.: Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet 1: 1126–1128, 1981.PubMedCrossRefGoogle Scholar
  536. Tatum, H.J.: Placental abruption. Obstet. Gynecol. 2: 447–453, 1953.PubMedGoogle Scholar
  537. Teasdale, F.: Histomorphometry of the placenta of the diabetic woman: class A diabetes mellitus. Placenta 2: 241–252, 1981.PubMedCrossRefGoogle Scholar
  538. Teasdale, F.: Histomorphometry of human placenta in class B diabetes mellitus. Placenta 4: 1–12, 1983.PubMedCrossRefGoogle Scholar
  539. Teasdale, F.: Histomorphometry of the human placenta in class C diabetes mellitus. Placenta 5: 69–86, 1984.CrossRefGoogle Scholar
  540. Teasdale, F.: Histomorphometry of the human placenta in maternal preeclampsia. Am. J. Obstet. Gynecol. 152: 25–31, 1985.PubMedGoogle Scholar
  541. Teasdale, F., and Ghislaine, J.-J.: Morphological changes in the placentas of smoking mothers: a histomorphometric study. Biol. Neonate 55: 251–259, 1989.PubMedCrossRefGoogle Scholar
  542. Tedeschi, L.G., and Tedeschi, C.G.: Experimental trophoblastic embolism and hyperplasminemia. Arch. Pathol. 76: 387–397, 1963.PubMedGoogle Scholar
  543. Tenney, B., and Parker, F.: The placenta in toxemia of pregnancy. Am. J. Obstet. Gynecol. 39: 1000–1005, 1940.Google Scholar
  544. Thomas, K., de Gasparo, M., and Hoet, J.J.: Insulin levels in the umbilical vein and in the umbilical artery of newborns of normal and gestational diabetic mothers. Diabetes 3: 299–304, 1967.Google Scholar
  545. Thomsen, K., and Lieschke, G.: Untersuchungen zur Placentamorphologie bei Diabetes mellitus. Acta Endocrinol. (Copenh.) 29: 602–614, 1958.Google Scholar
  546. Thornton, J.G., and Sampson, J.: Genetics of pre-eclampsia. Lancet 336: 1319–1320, 1990.PubMedCrossRefGoogle Scholar
  547. Thornton, Y.S., Birnbaum, S.J., and Lebowitz, N.: A viable pregnancy in a patient with myositis ossificans. Am. J. Obstet. Gynecol. 156: 577–578, 1987.PubMedGoogle Scholar
  548. Thorp, J.A., Walsh, S.W., and Brath, P.C.: Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am. J. Obstet. Gynecol. 159: 1381–1384, 1988.PubMedGoogle Scholar
  549. Toder, V., Blank, M., Gleicher, N., Voljovich, I., Mashiah, S., and Nebel, L.: Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis. Am. J. Obstet. Gynecol. 145: 7–10, 1983.PubMedGoogle Scholar
  550. Tominaga, T., and Page, E.W.: Accommodation of the human placenta to hypoxia. Am. J. Obstet. Gynecol. 84: 679–691, 1966.Google Scholar
  551. Torpin, R., and Swain, B.: Placental infarction in 1,000 cases correlated with the clinical findings. Am. J. Obstet. Gynecol. 94: 284–285, 1966.PubMedGoogle Scholar
  552. Trauscht-VanHorn, J., Capeless, E., Bovill, E.G., Easterling, T.R., and Hermanson, B.: Pregnancy loss and thrombosis with protein C deficiency in pregnancy [abstract 114]. Am. J. Obstet. Gynecol. 166: 311, 1992.Google Scholar
  553. Triplett, D.A.: Antiphospholipid antibodies and recurrent pregnancy loss. Am. J. Reprod. Immunol. 20: 52–67, 1989.PubMedGoogle Scholar
  554. Triplett, D.A.: Antiphospholipid antibodies and thrombosis: a consequence, coincidence, or cause ? Arch. Pathol. Lab. Med. 117: 78–88, 1993.PubMedGoogle Scholar
  555. Triplett, D.A., Brandt, J.T., and Maas, R.L.: The laboratory heterogeneity of lupus anticoagulant. Arch. Pathol. Lab. Med. 109: 946–951, 1985.PubMedGoogle Scholar
  556. Trudinger, B.J., Stewart, G.J., Cook, C.M., Connelly, A., and Exner, T.: Monitoring lupus anticoagulant-positive pregnancies with umbilical artery flow velocity waveforms. Obstet. Gynecol. 72: 215–218, 1988.PubMedGoogle Scholar
  557. Tsujimura, T., Matsumoto, K., and Aozasa, K.: Placental involvement by maternal non-Hodgkin’s lymphoma. Arch. Pathol. Lab. Med. 117: 325–327, 1993.PubMedGoogle Scholar
  558. Unander, A.M., Norberg, R., Hahn, L., and Arfors, L.: Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am. J. Obstet. Gynecol. 156: 114–119, 1987.PubMedGoogle Scholar
  559. Uzan, S., Beaufils, M., Breart G., Bazin, B., Capitant, C., and Paris, J.: Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 337: 1427–1431, 1991.PubMedCrossRefGoogle Scholar
  560. Vasquez-Escobosa, C., Perez-Medina, R., and Gomez-Estrada, H.: Circulating immune complexes in hypertensive disease of pregnancy. Obstet. Gynecol. 62: 45–48, 1982.Google Scholar
  561. Vassalli, P., Morris, R.H., and McCluskey, R.T.: The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy. J. Exp. Med. 118: 467–478, 1963.PubMedCrossRefGoogle Scholar
  562. Vintzileos, A.M., Campbell, W.A., Nochimson, D.J., and Weinbaum, P.J.: Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am. J. Obstet. Gynecol. 156: 1235–1238, 1987.PubMedGoogle Scholar
  563. Vogel, M.: Plakopathia diabetica. Virchows Arch. [Pathol. Anat.] 343: 51–63, 1967.Google Scholar
  564. Vogel, J.J., de Moerloose, P.A., and Bounameaux, H.: Protein C deficiency and pregnancy: a case report. Obstet. Gynecol. 73: 455–456, 1989.PubMedGoogle Scholar
  565. Voigt, L.F., Hollenbach, K.A., Krohn, M.A., Daling, J.R., and Hickok, D.E.: The relationship of abruptio placentae with maternal smoking and small for gestational age infants. Obstet. Gynecol. 75: 771–774, 1990.PubMedGoogle Scholar
  566. Vulsma, T., Gons, M.H., and de Vijlder, J.J.M.: Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N. Engl. J. Med. 321: 13–16, 1989.PubMedCrossRefGoogle Scholar
  567. Waddington, H.K.: Fetal salvage in abruptio placentae. Am. J. Obstet. Gynecol. 73: 812–816, 1957.Google Scholar
  568. Wagner, D.: Trophoblastic cells in the blood stream in normal and abnormal pregnancy. Acta Cytol. 12: 137–139, 1968.PubMedGoogle Scholar
  569. Wagner, D., Schunck, R., and Isebarth, H.: Der Nachweis von Trophoblastzellen im strömenden Blut der Frau bei normaler and gestörter Gravidität. Gynaecologia 158: 175–192, 1964.PubMedGoogle Scholar
  570. Wallenburg, H.C.S.: Über den Zusammenhang zwischen Spätgestose and Placentarinfarkt. Arch. Gynecol. 208: 80–90, 1969.Google Scholar
  571. Wallenburg, H.C.S., Hutchinson, D.L., Schuler, H.M., Stolte, L.A.M., and Janssens, J.: The pathogenesis of placental infarction. II. An experimental study in the rhesus monkey placenta. Am. J. Obstet. Gynecol. 116: 841–846, 1973a.PubMedGoogle Scholar
  572. Wallenburg, H.C.S., Stolte, L.A.M., and Janssens, J.: The pathogenesis of placental infarction. I. A morphologic study in the human placenta. Am. J. Obstet. Gynecol. 116: 835–840, 1973b.Google Scholar
  573. Walsh, S.W.: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152: 335–340, 1985.PubMedGoogle Scholar
  574. Walsh, S.W., Behr, M.J., and Allen, N.H.: Placental prostacyclin production in normal and toxemic pregnancies. Am. J. Obstet. Gynecol. 151: 110–115, 1985.PubMedGoogle Scholar
  575. Wapner, R.J., Cowchock, F.S., and Shapiro, S.S.: Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am. J. Obstet. Gynecol. 161: 1271–1272, 1989.PubMedGoogle Scholar
  576. Warrell, D.W., and Taylor, R.: Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet 1: 117–118, 1968.PubMedCrossRefGoogle Scholar
  577. Warren, R.J., Rimoin, D.L., and Sly, W.S.: LSD exposure in utero. Pediatrics 45: 466–469, 1970.PubMedGoogle Scholar
  578. Watov, S.E., and de Sandre, R.: Gaucher’s disease and pregnancy: report of one case involving four pregnancies. Obstet. Gynecol. 23: 247–250, 1964.PubMedGoogle Scholar
  579. Weathers, W.T., Crane, M.M., Sauvain, K.J., and Black-hurst, D.W.: Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants. Pediatrics 91: 350–354, 1993.PubMedGoogle Scholar
  580. Weiner, C., and Keller, S.: Preeclampsia is not associated with excess fetal clotting. Obstet. Gynecol. 68: 871–872, 1986.PubMedGoogle Scholar
  581. Weir, P.E.: Immunofluorescent studies of the uteroplacental arteries in normal pregnancy. Br. J. Obstet. Gynaecol. 88: 301–307, 1981.PubMedCrossRefGoogle Scholar
  582. Wells, M., and Bulmer, J.N.: The human placental bed: histology, immunohistochemistry and pathology. Histopathology 13: 483–498, 1988.PubMedCrossRefGoogle Scholar
  583. Wen, S.W., Goldenberg, R.L., Cutter, G.R., Hoffman, H.J., Cliver, S.P., Davis, R.O., and DuBard, M.B.: Smoking, maternal age, fetal growth, and gestational age at delivery. Am. J. Obstet. Gynecol. 162: 53–58, 1990.PubMedGoogle Scholar
  584. Wentworth, P.: Placental infarction and toxemia of pregnancy. Am. J. Obstet. Gynecol. 99: 318–326, 1967.PubMedGoogle Scholar
  585. Whalley, P.J., Pritchard, J.A., and Richards, J.R.: Sickle cell trait and pregnancy. J.A.M.A. 186: 1132–1135, 1963.PubMedCrossRefGoogle Scholar
  586. White, P.: Classification of obstetric diabetes. Am. J. Obstet. Gynecol. 130: 228–230, 1978.PubMedGoogle Scholar
  587. White, B.M., and Beischer, N.A.: Perinatal mortality in the infants of diabetic women. Aust. N.Z. J. Obstet. Gynaecol. 30: 323–326, 1990.PubMedCrossRefGoogle Scholar
  588. Widmaier, G.: Zur Ultrastruktur menschlicher Placentazotten beim Diabetes mellitus. Arch. Gynecol. 208: 396409, 1970.Google Scholar
  589. Wieland, R.G., Shaffer, M.B., and Glove, R.P.: Cushing’s syndrome complicating pregnancy: a case report. Obstet. Gynecol. 38: 841–843, 1971.PubMedGoogle Scholar
  590. Wielenga, G., and Willighagen, R.G.J.: Histochemical investigation of ischemic villi in the placenta. Am. J. Obstet. Gynecol. 96: 956–968, 1966.PubMedGoogle Scholar
  591. Willems, J.: The etiology of preeclampsia: a hypothesis. Obstet. Gynecol. 50: 495–499, 1977.PubMedGoogle Scholar
  592. Wingerd, J., Christianson, R., Lovitt, W.V., and Schoen, E.J.: Placental ratio in white and black women: relation to smoking and anemia. Am. J. Obstet. Gynecol. 124: 671–675, 1976.PubMedGoogle Scholar
  593. Winick, M., and Noble, A.: Cellular growth in human placenta. II. Diabetes mellitus. Am. J. Obstet. Gynecol. 71: 216–219, 1967.Google Scholar
  594. Winn, H.N., Setaro, J.F., Mazor, M., Reece, E.A., Black, H.R., and Hobbins, J.C.: Severe Takayasu’s arteritis in pregnancy: the role of central hemodynamic monitoring. Am. J. Obstet. Gynecol. 159: 1135–1136, 1988.PubMedGoogle Scholar
  595. Winston, H.G., and Mastroianni, L.: Sickle cell disease in pregnancy. Obstet. Gynecol. 2: 73–77, 1953.PubMedGoogle Scholar
  596. Wisot, A.L.: Silent abruptio placentae with marked hypofibrinogenemia. J.A.M.A. 207: 557–558, 1969.PubMedCrossRefGoogle Scholar
  597. Wladimiroff, J.W., Barentsen, R., Wallenburg, H.C.S., and Drogendijk, A.C.: Fetal urine production in a case of diabetes associated with polyhydramnios. Obstet. Gynecol. 46: 100–102, 1975.CrossRefGoogle Scholar
  598. Wolf, H., abata, V., Frerichs, H., and Stubbe, P.: Evidence for the impermeability of the human placenta for insulin. Horm. Metab. Res. 1: 274–275, 1969.PubMedCrossRefGoogle Scholar
  599. Woodhouse, S.: The lupus anticoagulant and the dilute Russell viper venom test. Pathologist July: 432–433, 1984.Google Scholar
  600. Woods, J.R., Plessinger, M.A., and Clark, K.E.: Effect of cocaine on uterine blood flow and fetal oxygenation. J.A.M.A. 257: 857–961, 1987.CrossRefGoogle Scholar
  601. Wurzel, J.M.: TTP lesions in placenta but not fetus. N. Engl. J. Med. 301: 503–504, 1979.Google Scholar
  602. Wynn, R.M.: The placenta in preeclampsia. Obstet. Gynecol. Annu. 6: 191–196, 1977.PubMedGoogle Scholar
  603. Xu, L., Chang, V., Murphy, A., Rock, J.A., Damewood, M., Schlaff, W., and Zacur, H.A.: Antinucléar antibodies in sera of patients with recurrent pregnancy wastage. Am. J. Obstet. Gynecol. 163:1493–1497, 1990. (For discussion see Am. J. Obstet. Gynecol. 166:1021–1022, 1992.)Google Scholar
  604. Ylikorkala, O., and Mkil, U.-M.: Prostacyclin and thromboxane in gynecology and obstetrics. Am. J. Obstet. Gynecol. 152: 318–329, 1985.PubMedGoogle Scholar
  605. Zacks, S., and Blazar, A.S.: Chorionic villi in normal pregnancy, pre-eclamptic toxemia, erythroblastosis, and diabetes mellitus: a light-and electron-microscope study. Obstet. Gynecol. 22: 149–167, 1963.PubMedGoogle Scholar
  606. Zeek, P.M., and Assali, N.S.: Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am. J. Clin. Pathol. 20: 1099–1109, 1950.PubMedGoogle Scholar
  607. Zhou, Y., Chiu, K., Brescia, R.J., Combs, C.A., Katz, M.A., Kitzmiller, J.L., Heilbron, D.C., and Fisher, S.J.: Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys. Am. J. Obstet. Gynecol. 169: 224–229, 1993.PubMedGoogle Scholar
  608. Zugaib, M., de Barros, A.C.S.D., Bittar, R.E., Burdmann, E.deA., and Neme, B.: Abruptio placentae following snake bite. Am. J. Obstet. Gynecol. 151: 754–755, 1985.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Kurt Benirschke
    • 1
  • Peter Kaufmann
    • 2
  1. 1.University Medical CenterUniversity of California, San DiegoSan DiegoUSA
  2. 2.Institut für Anatomie der Medizinischen FakultätRheinisch-Westfälische Technische Hochschule AachenAachenGermany

Personalised recommendations